<?xml version="1.0" ?>
<document version="1.8" entity_encoding="single">
  <page number="1">
    <text>THE UNIVERSITY OF
WESTERN
AUSTRALIA
Oral Health Centre
of Western Australia

**Oral cancer**

MAGDALEN FOO
DISCIPLINE LEAD ORAL MAXILLOFACIAL SURGERY</text>
    <formatted_text>*Magdalen Foo — Discipline Lead, Oral Maxillofacial Surgery*</formatted_text>
  </page>
  <page number="2">
    <text>THE UNIVERSITY OF
WESTERN
AUSTRALIA
Oral Health Centre
of Western Australia

Oral cancer

**Learning outcomes**

*   Describe the clinical aspect, diagnosis and management of oral cancer

Paranasal sinuses
Nasal cavity
Nasopharynx
Oral cavity
Pharynx
Oropharynx
Tongue
Salivary glands
Hypopharynx
Larynx

![Head and Neck Cancer Regions](W3 Oral Cancer - Foo_figures/img_31026ce72d3f5667.webp)</text>
    <formatted_text>- Describe the clinical aspect, diagnosis and management of oral cancer

**Anatomical sites:**

- Paranasal sinuses
- Nasal cavity
- Nasopharynx
- Oral cavity
- Pharynx
- Oropharynx
- Tongue
- Salivary glands
- Hypopharynx
- Larynx</formatted_text>
    <images>
      <img order="0" bbox="509,243,894,851" bbox_format="xyxy_norm_1000" bbox_origin="top_left" bbox_space="page" type="image" path="W3 Oral Cancer - Foo_figures/img_31026ce72d3f5667.webp" caption="Head and Neck Cancer Regions"/>
    </images>
  </page>
  <page number="3">
    <text>THE UNIVERSITY OF WESTERN AUSTRALIA | Oral Health Centre of Western Australia

Head and neck cancer statistics in Australia

*   &gt; 5000 **new cases** of head and neck cancer diagnosed in 2020 (¾ = males, ¼ = females)
*   3.6% of all new cancer cases diagnosed in 2020
*   Head and neck cancers (including lip) - 7th most commonly diagnosed cancers in Australia
*   65.1 is the average age of diagnosis

*   &gt; 1000 **deaths** from head and neck cancer (including lip) in 2020
*   2.4% of all deaths from cancer in 2020
*   70% surviving at least 5 years (2012–2016)</text>
    <formatted_text>#### Head and Neck Cancer Statistics in Australia

**Incidence**

- &gt; 5000 **new cases** of head and neck cancer diagnosed in 2020 (¾ = males, ¼ = females)
- 3.6% of all new cancer cases diagnosed in 2020
- Head and neck cancers (including lip) — 7th most commonly diagnosed cancers in Australia
- 65.1 is the average age of diagnosis

**Mortality**

- &gt; 1000 **deaths** from head and neck cancer (including lip) in 2020
- 2.4% of all deaths from cancer in 2020
- 70% surviving at least 5 years (2012–2016)</formatted_text>
  </page>
  <page number="4">
    <text>THE UNIVERSITY OF
WESTERN
AUSTRALIA
Oral Health Centre
of Western Australia

# Oral cancer

*   Lips
*   Anterior 2/3 of the tongue
*   Floor of the mouth and ventral tongue
*   Hard palate and soft palate
*   Gingiva
*   Buccal mucosa
*   Metastasis from another location in the body
*   Direct spread from surrounding areas e.g. nasal cavity
*   The majority of oral cancers are Squamous Cell Carcinomas
*   Rarer types of oral cancer start in the salivary glands
*   Lymphomas and Melanomas might also be diagnosed around the oral cavity - approached differently in terms of treatment</text>
    <formatted_text>#### Sites and Origins of Oral Cancer

Oral cancer may arise at the following sites:

- Lips
- Anterior 2/3 of the tongue
- Floor of the mouth and ventral tongue
- Hard palate and soft palate
- Gingiva
- Buccal mucosa

It may also arise from:

- Metastasis from another location in the body
- Direct spread from surrounding areas, e.g. nasal cavity

#### Types of Oral Cancer

- The majority of oral cancers are Squamous Cell Carcinomas
- Rarer types of oral cancer start in the salivary glands
- Lymphomas and Melanomas might also be diagnosed around the oral cavity — approached differently in terms of treatment</formatted_text>
    <audio_inserts count="2">
      <insert timestamp="00:19:13" confidence="3" anchor="- Direct spread from surrounding areas, e.g. nasal cavity">
- ==The retromolar region==
- ==The lateral and ventral surfaces of the anterior two-thirds of the tongue==</insert>
      <insert timestamp="00:04:42" confidence="4" anchor="- Direct spread from surrounding areas, e.g. nasal cavity">

&gt; [!note] Lecturer — Oral Cancer Boundaries
&gt; The posterior third of the tongue belongs to the oropharynx rather than the oral cavity.
&gt;
&gt; - It has different symptoms and referral pathways.
&gt; - The dorsum of the tongue is not the usual site for oral carcinoma; a lump there is more likely to represent something benign or another condition.
&gt; - A large tumour in the sinus cavity may spread rapidly into the upper jaw or nose because the sinus is largely air-filled.
</insert>
    </audio_inserts>
  </page>
  <page number="5">
    <text>THE UNIVERSITY OF
WESTERN
AUSTRALIA
SEEK WISDOM
Oral Health Centre
of Western Australia

Squamous cell carcinoma (SCC)

- **Squamous cell carcinoma** represents **90%** of all oral cancers

![](W3 Oral Cancer - Foo_figures/img_06cb50b40e554ce1.webp)
![](W3 Oral Cancer - Foo_figures/img_74363d1e9c3f44bc.webp)</text>
    <formatted_text>- **Squamous cell carcinoma** represents **90%** of all oral cancers</formatted_text>
    <audio_inserts count="2">
      <insert timestamp="00:09:35" confidence="6" anchor="- **Squamous cell carcinoma** represents **90%** of all oral cancers">

&gt; [!note] Lecturer — Squamous Cell Presentation
&gt; Approximately 90–95% of tumours in the mouth are squamous cell carcinomas, which may initially present in several different ways.
&gt;
&gt; - A non-healing ulcer, red or white patch, indurated lesion, or mass
&gt; - Localised bone loss or unusually mobile teeth
&gt; - Oral cancer is not always painful, particularly when it affects the ventral tongue or floor of the mouth.
</insert>
      <insert timestamp="00:06:06" confidence="6" anchor="### **Squamous Cell Carcinoma**  - **Squamous cell carcinoma** represents **90%*">

&gt; [!note] Lecturer — Salivary Gland Tumours
&gt; The likelihood that a salivary gland tumour is malignant varies according to the gland involved.
&gt;
&gt; - Parotid gland: approximately 20% malignant and 80% likely to be benign
&gt; - Submandibular gland: approximately a 50:50 likelihood of being benign or malignant
&gt; - Minor salivary glands: more likely to be malignant
&gt; - A lower-lip lump is commonly a mucous retention phenomenon caused by lip biting and blockage of a gland.
&gt; - An upper-lip tumour is more likely to relate to a minor salivary gland and therefore requires consideration of malignancy.
</insert>
    </audio_inserts>
    <images>
      <img order="0" bbox="169,498,527,870" bbox_format="xyxy_norm_1000" bbox_origin="top_left" bbox_space="page" type="figure" path="W3 Oral Cancer - Foo_figures/img_06cb50b40e554ce1.webp">
        <description>Radiograph: A panoramic dental X-ray (orthopantomogram) showing the maxilla and mandible. The image displays multiple teeth, including several with radiopaque restorations or crowns, as well as evidence of tooth loss in various regions.</description>
      </img>
      <img order="1" bbox="546,490,883,900" bbox_format="xyxy_norm_1000" bbox_origin="top_left" bbox_space="page" type="photo" path="W3 Oral Cancer - Foo_figures/img_74363d1e9c3f44bc.webp">
        <description>Clinical photo showing an intraoral view of the lower anterior teeth and gingiva. A large, ulcerated lesion with a necrotic center and raised borders is visible on the lower gum line between the teeth.</description>
      </img>
    </images>
  </page>
  <page number="6">
    <text>SCC lateral tongue

![](W3 Oral Cancer - Foo_figures/img_3f13a8dba0752aaf.webp)
![](W3 Oral Cancer - Foo_figures/img_67c3671039cfa144.webp)</text>
    <formatted_text>*SCC lateral tongue*</formatted_text>
    <images>
      <img order="0" bbox="49,120,436,577" bbox_format="xyxy_norm_1000" bbox_origin="top_left" bbox_space="page" type="photo" path="W3 Oral Cancer - Foo_figures/img_3f13a8dba0752aaf.webp">
        <description>Clinical photograph showing the lateral aspect of a human tongue with a visible pathological lesion. The mass appears as an irregular, erythematous (red) and white area on the side of the tongue, featuring central ulceration and raised borders.</description>
      </img>
      <img order="1" bbox="446,274,951,625" bbox_format="xyxy_norm_1000" bbox_origin="top_left" bbox_space="page" type="photo" path="W3 Oral Cancer - Foo_figures/img_67c3671039cfa144.webp">
        <description>Clinical photo: An intraoral view showing a raised, irregular red lesion on the lateral aspect of the tongue. The lesion appears exophytic and erythematous with a granular texture, contrasting with the surrounding pink mucosa.</description>
      </img>
    </images>
  </page>
  <page number="7">
    <text>SCC floor of mouth

![](W3 Oral Cancer - Foo_figures/img_d6b808057f4543b3.webp)
![](W3 Oral Cancer - Foo_figures/img_61632d6690212fd6.webp)</text>
    <formatted_text>*SCC floor of mouth*</formatted_text>
    <images>
      <img order="0" bbox="56,144,498,452" bbox_format="xyxy_norm_1000" bbox_origin="top_left" bbox_space="page" type="image" path="W3 Oral Cancer - Foo_figures/img_d6b808057f4543b3.webp"/>
      <img order="1" bbox="547,181,902,640" bbox_format="xyxy_norm_1000" bbox_origin="top_left" bbox_space="page" type="photo" path="W3 Oral Cancer - Foo_figures/img_61632d6690212fd6.webp">
        <description>Clinical photo: An intraoral view showing the floor of the mouth and anterior mandibular teeth. A raised, irregular, erythematous lesion is visible on the soft tissue in the midline near the frenulum.</description>
      </img>
    </images>
  </page>
  <page number="8">
    <text>Salivary gland carcinoma

![](W3 Oral Cancer - Foo_figures/img_314c0a8c85e6808f.webp)
![](W3 Oral Cancer - Foo_figures/img_38cf242d2a98dd25.webp)
![](W3 Oral Cancer - Foo_figures/img_98296adc8231851f.webp)</text>
    <formatted_text>*Salivary gland carcinoma*</formatted_text>
    <images>
      <img order="0" bbox="134,340,391,626" bbox_format="xyxy_norm_1000" bbox_origin="top_left" bbox_space="page" type="photo" path="W3 Oral Cancer - Foo_figures/img_314c0a8c85e6808f.webp">
        <description>Clinical photo: An intraoral view showing the upper right posterior palate and maxillary teeth. There is a visible, smooth, pink swelling on the hard palate adjacent to the molar region.</description>
      </img>
      <img order="1" bbox="134,631,391,935" bbox_format="xyxy_norm_1000" bbox_origin="top_left" bbox_space="page" type="photo" path="W3 Oral Cancer - Foo_figures/img_38cf242d2a98dd25.webp">
        <description>Clinical photo: An intraoral view showing the maxillary arch with a dental mirror retracting the upper lip and a dental instrument examining the posterior buccal mucosa. The image highlights a reddish, irregular lesion in the soft tissue area adjacent to the molars.</description>
      </img>
      <img order="2" bbox="420,436,817,856" bbox_format="xyxy_norm_1000" bbox_origin="top_left" bbox_space="page" type="photo" path="W3 Oral Cancer - Foo_figures/img_98296adc8231851f.webp">
        <description>A panoramic radiograph (orthopantomogram) of the maxillofacial region, displaying the full dentition, mandible, and maxilla. The image reveals a large, dark radiolucent area in the posterior right mandible (left side of the image), indicating significant bone loss or pathology.</description>
      </img>
    </images>
  </page>
  <page number="9">
    <text>Metastasis to the jaws

*   Uncommon (&lt;1% of cancer in the oral cavity)
*   Metastasize to the mandible, less so to the maxilla
*   Majority of tumours are adenocarcinomas
*   Origins of primary tumour – breast(30%), lungs(20%), kidney(15%), thyroid(5%), prostate(5%), colon(5%), stomach(5%), cutaneous melanoma(5%)
*   Radiographic appearance at site of metastatic tumour deposit – ill defined radiolucency / radiopacity or mixed radiolucent and radiopaque lesions
*   Can be asymptomatic, or patient may experience pain, loosening of teeth, or unilateral paraesthesia of the lower lip/chin</text>
    <formatted_text>#### Clinical Features

- Uncommon (&lt;1% of cancer in the oral cavity)
- Metastasize to the mandible, less so to the maxilla
- Majority of tumours are adenocarcinomas

#### Primary Tumour Origins

- Breast (30%)
- Lungs (20%)
- Kidney (15%)
- Thyroid (5%)
- Prostate (5%)
- Colon (5%)
- Stomach (5%)
- Cutaneous melanoma (5%)

#### Radiographic and Symptomatic Presentation

- Radiographic appearance at site of metastatic tumour deposit — ill defined radiolucency / radiopacity or mixed radiolucent and radiopaque lesions
- Can be asymptomatic, or patient may experience pain, loosening of teeth, or unilateral paraesthesia of the lower lip/chin</formatted_text>
    <audio_inserts count="3">
      <insert timestamp="00:14:43" confidence="5" anchor="- Cutaneous melanoma (5%)">

&gt; [!note] Lecturer — Jaw Metastasis Assessment
&gt; Metastatic lesions may present with localised bone loss, unusually mobile teeth, bleeding around teeth, a non-healing ulcer, or numbness caused by nerve involvement.
&gt;
&gt; - A numb lower lip may indicate involvement of the inferior alveolar nerve.
&gt; - In the maxilla, infraorbital nerve involvement may cause numbness of the upper lip or side of the nose.
&gt; - A history of previous cancer is important when assessing a new oral or jaw lesion.
</insert>
      <insert timestamp="00:07:33" confidence="3" anchor="- Radiographic appearance at site of metastatic tumour deposit — ill defined rad">

&gt; [!note] Lecturer — Metastatic Bone Loss
&gt; Metastatic jaw lesions may resemble periodontal disease or an odontogenic problem but show an unusual pattern of destruction.
&gt;
&gt; - Imaging may show generalised bone loss, more severe localised bone loss around particular teeth, a large area of bone destruction, or an unusual area of mandibular bone loss.
&gt; - An OPG, periapical radiograph, CT, or other imaging may demonstrate the extent of bone involvement.
&gt; - Further consideration is warranted when bone loss does not correspond with the general periodontal condition or when a swelling does not behave like an infection.
</insert>
      <insert timestamp="00:15:54" confidence="3" anchor="- Can be asymptomatic, or patient may experience pain, loosening of teeth, or un">

&gt; [!note] Lecturer — Other Oral Cancers
&gt; Lymphoma may involve the oral cavity and jaws and can initially resemble an odontogenic or periodontal problem when swelling and marked localised bone loss are present.
&gt;
&gt; - Rare cancers around the oral cavity also include mucosal melanoma.
&gt; - Oral mucosal melanoma may invade soft tissues, be extensively pigmented, cause bleeding and mobility of teeth, and cause bone loss if it invades bone.
&gt; - A tumour involving the uvula or soft palate may interfere with speech and soft-palate function, so the patient may be unable to say “ah” properly and may have a nasal quality to their speech.
</insert>
    </audio_inserts>
  </page>
  <page number="10">
    <text>Metastasis to the jaws

![](W3 Oral Cancer - Foo_figures/img_a7d128c63d2fa077.webp)
![](W3 Oral Cancer - Foo_figures/img_fa13e42947145fbd.webp)
![](W3 Oral Cancer - Foo_figures/img_8b2ba7095e2c001a.webp)</text>
    <formatted_text>*Metastasis to the jaws*</formatted_text>
    <images>
      <img order="0" bbox="69,451,355,832" bbox_format="xyxy_norm_1000" bbox_origin="top_left" bbox_space="page" type="image" path="W3 Oral Cancer - Foo_figures/img_a7d128c63d2fa077.webp"/>
      <img order="1" bbox="369,386,641,872" bbox_format="xyxy_norm_1000" bbox_origin="top_left" bbox_space="page" type="figure" path="W3 Oral Cancer - Foo_figures/img_fa13e42947145fbd.webp">
        <description>Radiograph: An axial computed tomography (CT) scan of the maxillofacial region showing a cross-section of the jaws. The image displays high-density structures corresponding to teeth and bone, with a notable area of radiolucency (darkness) and structural disruption in the left posterior maxilla/zygomatic region, consistent with osteolytic metastatic disease.</description>
      </img>
      <img order="2" bbox="650,380,929,878" bbox_format="xyxy_norm_1000" bbox_origin="top_left" bbox_space="page" type="figure" path="W3 Oral Cancer - Foo_figures/img_8b2ba7095e2c001a.webp">
        <description>A 3D reconstructed computed tomography (CT) scan of a human skull shown in an anterior view. The image reveals a large, destructive radiolucent lesion involving the left mandibular body and ramus, characterized by significant bone loss and a pathological fracture through the affected area.</description>
      </img>
    </images>
  </page>
  <page number="11">
    <text>Other cancers around the oral cavity

![A](W3 Oral Cancer - Foo_figures/img_ccd00fe207148f1e.webp)
![](W3 Oral Cancer - Foo_figures/img_ca3d4cb4e402d477.webp)</text>
    <formatted_text>*Other cancers around the oral cavity*</formatted_text>
    <images>
      <img order="0" bbox="114,394,453,867" bbox_format="xyxy_norm_1000" bbox_origin="top_left" bbox_space="page" type="photo" path="W3 Oral Cancer - Foo_figures/img_ccd00fe207148f1e.webp" caption="A">
        <description>Clinical photograph showing the oral cavity with a large, dark purple-black mass involving the upper gingiva and hard palate. The lesion appears raised and nodular, with some areas of surface ulceration or whitish discoloration, extending from the gum line up towards the roof of the mouth.</description>
      </img>
      <img order="1" bbox="509,375,907,889" bbox_format="xyxy_norm_1000" bbox_origin="top_left" bbox_space="page" type="photo" path="W3 Oral Cancer - Foo_figures/img_ca3d4cb4e402d477.webp">
        <description>Clinical photograph showing an intraoral view of the oral cavity, specifically highlighting a large, irregular, reddish mass or lesion located on the soft palate and uvula area.</description>
      </img>
    </images>
  </page>
  <page number="12">
    <text>THE UNIVERSITY OF
WESTERN
AUSTRALIA
SEEK WISDOM

Oral Health Centre
of Western Australia

# Oral Squamous Cell Carcinoma

*   The main risk factors are **tobacco** and **alcohol** consumption (Note synergistic)

![](W3 Oral Cancer - Foo_figures/img_149ab76233903ef8.webp)</text>
    <formatted_text>### Oral Squamous Cell Carcinoma

- The main risk factors are **tobacco** and **alcohol** consumption (note synergistic).</formatted_text>
    <audio_inserts count="1">
      <insert timestamp="00:20:28" confidence="3" anchor="- The main risk factors are **tobacco** and **alcohol** consumption (note synerg">

&gt; [!note] Lecturer — Oral Cancer Progression
&gt; The clinician should consider both the lesion and the patient’s lifestyle when deciding whether a presentation is suspicious.
&gt;
&gt; - Oral cancer does not usually develop overnight; it may progress from normal tissue through changes or premalignant conditions before cancer develops.
</insert>
    </audio_inserts>
    <images>
      <img order="0" bbox="283,471,700,893" bbox_format="xyxy_norm_1000" bbox_origin="top_left" bbox_space="page" type="photo" path="W3 Oral Cancer - Foo_figures/img_149ab76233903ef8.webp">
        <description>A close-up photograph showing a metal ashtray with lit cigarettes and smoke next to a glass of amber liquid with ice cubes, illustrating the synergistic risk factors of tobacco and alcohol consumption.</description>
      </img>
    </images>
  </page>
  <page number="13">
    <text>“ Synergistic consumption of alcohol and tobacco (both smoked and smokeless) significantly increased the odds for the occurrence of Oral Squamous Cell Carcinoma ”

Clin Oral Investig. 2019 Jul;23(7):2849-2859

The synergistic effect of tobacco and alcohol consumption on oral squamous cell carcinoma: a systematic review and meta-analysis

Fernanda Weber Mello, Gilberto Melo , Júlia Jacoby Pasetto , Carolina Amália Barcellos Silva , Saman Warnakulasuriya , Elena Riet Correa Rivero</text>
    <formatted_text>&gt; &quot;Synergistic consumption of alcohol and tobacco (both smoked and smokeless) significantly increased the odds for the occurrence of Oral Squamous Cell Carcinoma&quot;

*Clin Oral Investig. 2019 Jul;23(7):2849-2859*

*The synergistic effect of tobacco and alcohol consumption on oral squamous cell carcinoma: a systematic review and meta-analysis*

Fernanda Weber Mello, Gilberto Melo, Júlia Jacoby Pasetto, Carolina Amália Barcellos Silva, Saman Warnakulasuriya, Elena Riet Correa Rivero</formatted_text>
    <audio_inserts count="1">
      <insert timestamp="00:10:11" confidence="3" anchor="&gt; &quot;Synergistic consumption of alcohol and tobacco (both smoked and smokeless) si">

&gt; [!note] Lecturer — Suspicious Lesions
&gt; A patient who smokes and drinks heavily and presents with a non-healing, indurated lesion should prompt a high index of suspicion. Clinicians are not expected to diagnose oral cancer in the dental clinic; they are expected to recognise suspicious findings and arrange referral or biopsy.
</insert>
    </audio_inserts>
  </page>
  <page number="14">
    <text>THE UNIVERSITY OF
WESTERN
AUSTRALIA
Oral Health Centre
of Western Australia

Oral cancer

Other risk factors :
*   Human papilloma virus (HPV)
*   chewing pan (areca or betel nut)
*   Epstein-Barr virus (EBV) – for nasopharyngeal carcinoma
*   exposure to the sun
*   family history of mouth cancers / inherited conditions e.g. Fanconi anaemia
*   post transplant / immunosuppressed
*   Oral premalignant conditions</text>
    <formatted_text>Other risk factors:

- Human papilloma virus (HPV)
- Chewing pan (areca or betel nut)
- Epstein-Barr virus (EBV) — for nasopharyngeal carcinoma
- Exposure to the sun
- Family history of mouth cancers / inherited conditions, e.g. Fanconi anaemia
- Post transplant / immunosuppressed
- Oral premalignant conditions</formatted_text>
    <audio_inserts count="1">
      <insert timestamp="00:20:22" confidence="5" anchor="- Oral premalignant conditions">

&gt; [!note] Lecturer — Additional Risk Details
&gt; Betel-nut chewing is particularly associated with cancer of the buccal mucosa because the material is stored in the buccal sulcus.
&gt;
&gt; - Long-term sun exposure may lead to changes in the lips that eventually become lip cancer.
&gt; - Immunosuppressed patients are at increased risk of cancer because their tissues may not repair abnormal changes effectively.
</insert>
    </audio_inserts>
  </page>
  <page number="15">
    <text>**DRINKING GUIDELINES AROUND THE WORLD**

Limit per week (units)*
Country | Men | Women
---|---|---
Spain | 35 | 21.3
Canada | 25.5 | 17
USA | 24.5 | 12.3
China | 21.9 | 13
Philippines | 21 | 10.5
New Zealand | 18.8 | 12.5
Sweden | 17.5 | 8.8
Vietnam | 17.5 | 8.75

Limit per week (units)*
Country | Men | Women
---|---|---
Germany | 15 | 7.5
UK | 14 | 14
Australia | 12.5 | 12.5
France | 12.5 | 12.5
Japan | 12.5 | 6.3
Netherlands | 8.8 | 8.8
Guyana | 7 | 7

*Note, measurements and guidelines vary globally; comparisons are based on one unit containing 8g of alcohol.

![DRINKING GUIDELINES AROUND THE WORLD](W3 Oral Cancer - Foo_figures/img_6a48dc2135e8d9bd.webp)
![](W3 Oral Cancer - Foo_figures/img_afd8ad725b1c014d.webp)
![](W3 Oral Cancer - Foo_figures/img_2880704a7ab10e09.webp)</text>
    <formatted_text>#### Drinking Guidelines Around the World

**Limit per week (units)\***

| Country | Men | Women |
|---|---|---|
| Spain | 35 | 21.3 |
| Canada | 25.5 | 17 |
| USA | 24.5 | 12.3 |
| China | 21.9 | 13 |
| Philippines | 21 | 10.5 |
| New Zealand | 18.8 | 12.5 |
| Sweden | 17.5 | 8.8 |
| Vietnam | 17.5 | 8.75 |

| Country | Men | Women |
|---|---|---|
| Germany | 15 | 7.5 |
| UK | 14 | 14 |
| Australia | 12.5 | 12.5 |
| France | 12.5 | 12.5 |
| Japan | 12.5 | 6.3 |
| Netherlands | 8.8 | 8.8 |
| Guyana | 7 | 7 |

\*Note, measurements and guidelines vary globally; comparisons are based on one unit containing 8g of alcohol.</formatted_text>
    <images>
      <img order="0" bbox="48,37,671,545" bbox_format="xyxy_norm_1000" bbox_origin="top_left" bbox_space="page" type="image" path="W3 Oral Cancer - Foo_figures/img_6a48dc2135e8d9bd.webp" caption="DRINKING GUIDELINES AROUND THE WORLD"/>
      <img order="1" bbox="211,604,357,922" bbox_format="xyxy_norm_1000" bbox_origin="top_left" bbox_space="page" type="table" path="W3 Oral Cancer - Foo_figures/img_afd8ad725b1c014d.webp">
        <description>A cropped portion of a data table listing countries (Spain, Canada, USA, China, Philippines, New Zealand, Sweden, Vietnam) with their corresponding weekly alcohol consumption limits for men in units.</description>
      </img>
      <img order="2" bbox="448,603,655,921" bbox_format="xyxy_norm_1000" bbox_origin="top_left" bbox_space="page" type="table" path="W3 Oral Cancer - Foo_figures/img_2880704a7ab10e09.webp">
        <description>Table: A cropped section of a data table listing weekly alcohol consumption limits in units for Men and Women across several countries, including Germany, UK, Australia, France, Japan, Netherlands, and Guyana. The row for Australia is highlighted by a red hand-drawn oval.</description>
      </img>
    </images>
  </page>
  <page number="16">
    <text>RACGP | *Supporting smoking cessation*
Royal Australian College of General Practitioners

**A guide for health professionals**
Second edition

Quit Smoking

racgp.org.au
Healthy Profession. Healthy Australia.

---

### Chemicals in a Cigarette

* **Stearic Acid**: Candle Wax
* **Haxamine**: Barbecue Lighter
* **Ammonia**: Toilet Cleaner
* **BUTANE**: Lighter Fluid
* **Benzene**: Petrol Fumes
* **Tolunene**: Industrial Solvent
* **Arsenic**: Poison
* **Nicotine**: Insecticide
* **Carbon Monoxide**
* **Acetic Acid**: Vinegar
* **Cadmium**: Batteries
* **Methanol**: Rocket Fuel
* **Acetone**: Paint stripper, Nail varnish

![](W3 Oral Cancer - Foo_figures/img_f8cf7db4410067c6.webp)</text>
    <formatted_text>*RACGP — Supporting smoking cessation. Royal Australian College of General Practitioners. A guide for health professionals, second edition. racgp.org.au*

#### Chemicals in a Cigarette

- Stearic Acid — candle wax
- Hexamine — barbecue lighter
- Ammonia — toilet cleaner
- Butane — lighter fluid
- Benzene — petrol fumes
- Toluene — industrial solvent
- Arsenic — poison
- Nicotine — insecticide
- Carbon Monoxide
- Acetic Acid — vinegar
- Cadmium — batteries
- Methanol — rocket fuel
- Acetone — paint stripper, nail varnish</formatted_text>
    <images>
      <img order="0" bbox="441,184,952,902" bbox_format="xyxy_norm_1000" bbox_origin="top_left" bbox_space="page" type="diagram" path="W3 Oral Cancer - Foo_figures/img_f8cf7db4410067c6.webp">
        <description>This diagram illustrates a cigarette surrounded by labels identifying various chemicals found within it, along with common household or industrial products that contain those same substances. The labels point to different parts of the cigarette and include: Stearic Acid (Candle Wax), Hexamine (Barbecue Lighter), Ammonia (Toilet Cleaner), BUTANE (Lighter Fluid), Benzene (Petrol Fumes), Toluene (Industrial Solvent), Arsenic (Poison), Nicotine (Insecticide), Carbon Monoxide, Acetic Acid (Vinegar), Cadmium (Batteries), Methanol (Rocket Fuel), and Acetone (Paint stripper, Nail varnish).</description>
      </img>
    </images>
  </page>
  <page number="17">
    <text>![](W3 Oral Cancer - Foo_figures/img_965252d3baf2b4ea.webp)
![](W3 Oral Cancer - Foo_figures/img_41014b4d1fbc3a48.webp)
![](W3 Oral Cancer - Foo_figures/img_28e4a410293b2170.webp)
![](W3 Oral Cancer - Foo_figures/img_0598759b1de1d4a2.webp)</text>
    <images>
      <img order="0" bbox="74,68,392,490" bbox_format="xyxy_norm_1000" bbox_origin="top_left" bbox_space="page" type="photo" path="W3 Oral Cancer - Foo_figures/img_965252d3baf2b4ea.webp">
        <description>A photograph of the sun shining brightly against a clear blue sky, with visible lens flare artifacts.</description>
      </img>
      <img order="1" bbox="85,540,413,932" bbox_format="xyxy_norm_1000" bbox_origin="top_left" bbox_space="page" type="photo" path="W3 Oral Cancer - Foo_figures/img_41014b4d1fbc3a48.webp">
        <description>Clinical photo: A close-up view of a patient's lower lip exhibiting a large, diffuse lesion characterized by redness, swelling, and extensive yellowish-white crusting.</description>
      </img>
      <img order="2" bbox="441,42,743,451" bbox_format="xyxy_norm_1000" bbox_origin="top_left" bbox_space="page" type="image" path="W3 Oral Cancer - Foo_figures/img_28e4a410293b2170.webp"/>
      <img order="3" bbox="480,466,850,948" bbox_format="xyxy_norm_1000" bbox_origin="top_left" bbox_space="page" type="photo" path="W3 Oral Cancer - Foo_figures/img_0598759b1de1d4a2.webp">
        <description>Clinical intraoral photograph showing a large, irregular, erythematous and white lesion on the floor of the mouth/ventral tongue area. The surrounding teeth exhibit significant brown discoloration or staining, particularly near the gumline.</description>
      </img>
    </images>
  </page>
  <page number="18">
    <text>THE UNIVERSITY OF WESTERN AUSTRALIA

Oral Health Centre of Western Australia

## Oropharyngeal SCC

**Oral HPV 16 is a strong risk factor**

![](W3 Oral Cancer - Foo_figures/img_ab8792af942e3255.webp)</text>
    <formatted_text>### Oropharyngeal SCC

**Oral HPV 16 is a strong risk factor.**</formatted_text>
    <images>
      <img order="0" bbox="473,215,907,808" bbox_format="xyxy_norm_1000" bbox_origin="top_left" bbox_space="page" type="image" path="W3 Oral Cancer - Foo_figures/img_ab8792af942e3255.webp"/>
    </images>
  </page>
  <page number="19">
    <text>“ This study corroborates and extends Australian data demonstrating that patients with HPV-positive OPSCC represent a distinct subgroup associated with a significantly better survival ”

Australian Journal of Otolaryngology, Vol 2 (2019)

Human papillomavirus and oropharyngeal squamous cell carcinoma: a 12-year retrospective review in a New South Wales tertiary referral centre

Alon Taylor, Thomas Eade, David Veivers, Anthony J. Gill, Leo Pang</text>
    <formatted_text>&gt; &quot;This study corroborates and extends Australian data demonstrating that patients with HPV-positive OPSCC represent a distinct subgroup associated with a significantly better survival&quot;

*Australian Journal of Otolaryngology, Vol 2 (2019)*

*Human papillomavirus and oropharyngeal squamous cell carcinoma: a 12-year retrospective review in a New South Wales tertiary referral centre*

Alon Taylor, Thomas Eade, David Veivers, Anthony J. Gill, Leo Pang</formatted_text>
    <audio_inserts count="1">
      <insert timestamp="00:26:58" confidence="9" anchor="Human papillomavirus and oropharyngeal squamous cell carcinoma: a 12-year retros">

&gt; [!note] Lecturer — Oropharyngeal HPV
&gt; HPV was discussed primarily as a risk factor for oropharyngeal cancer involving the posterior third of the tongue, which is separate from the oral cavity region and managed through an ENT pathway.
&gt;
&gt; - Patients may present with a lump in the neck, difficulty swallowing, unintentional weight loss, changes in speech, or pain referred to the ear.
&gt; - HPV types 16 and 18 were identified, and HPV-associated disease may have better outcomes than disease in patients without the usual risk factors.
&gt; - Vaccination of boys and girls was discussed in relation to reducing HPV-associated oropharyngeal cancer.
</insert>
    </audio_inserts>
  </page>
  <page number="20">
    <text>THE UNIVERSITY OF
WESTERN
AUSTRALIA
Oral Health Centre
of Western Australia

Oral cancer

Symptoms can include:
a lump in the neck
mobile teeth
swelling or a sore on the lip that won't heal
difficult or painful swallowing
changes in speech
bleeding or numbness in the mouth
white or red patches on the mouth, tongue or gums
unexplained weight loss

![](W3 Oral Cancer - Foo_figures/img_31c3260717e4b14e.webp)</text>
    <formatted_text>Symptoms can include:

- a lump in the neck
- mobile teeth
- swelling or a sore on the lip that won't heal
- difficult or painful swallowing
- changes in speech
- bleeding or numbness in the mouth
- white or red patches on the mouth, tongue or gums
- unexplained weight loss</formatted_text>
    <audio_inserts count="1">
      <insert timestamp="00:11:28" confidence="5" anchor="bleeding or numbness in the mouth - white or red patches on the mouth, tongue or">

- ==An ulcer that does not heal within two or three weeks==
- ==An indurated ulcer==
- ==Localised, unexplained tooth mobility==
- ==Localised bone loss==
- ==Bleeding around teeth in an unusual localised area==
- ==Unexplained numbness of the lip, face, or nose==

&gt; [!note] Lecturer — Early Oral Cancer
&gt; Most early oral cancers are painless, so a lesion under the tongue may go unnoticed because it does not cause pain.
&gt;
&gt; - A red patch was described as more concerning than a white patch.
&gt; - Lip cancer may present as an ulcerated, indurated, non-healing area, particularly in a patient with substantial sun exposure.
&gt;
&gt; [!note] Lecturer — Neck Lump Assessment
&gt; A neck lump may initially be caused by infection, which is the most common cause of lymphadenopathy.
&gt;
&gt; - If the lump persists after review, suspicion should increase.
&gt;
&gt; [!note] Lecturer — Submandibular Obstruction
&gt; A tumour near the submandibular duct may present as a blocked submandibular gland rather than as obvious pain from the oral tumour.
&gt;
&gt; - A blocked gland should prompt consideration of infection, a salivary stone, or a tumour obstructing the duct.
&gt; - A gland blocked by a stone may intermittently improve and may be associated with sludge or fluid discharge.
&gt; - Tumour-related obstruction is less likely to resolve.
&gt;
&gt; [!example] Non-Healing Ulcer With Localised Bone Loss
&gt; A patient presented with an ulcer in the lower anterior region, generalised bone loss that was more pronounced around the lower anterior teeth, a loose bridge, food impaction, and an ulcer that would not heal.
&gt;
&gt; - The presentation could initially have been attributed to periodontal disease.
&gt; - Because the bone loss and ulcer were localised and did not fit the overall periodontal presentation, further investigation was required.
&gt; - The lesion was ultimately found to be cancer involving the bone.
&gt;
&gt; [!example] Blocked Submandibular Gland
&gt; A tumour near the opening of the submandibular duct prevented the gland from emptying.
&gt;
&gt; - The patient could therefore present with a blocked submandibular gland rather than obvious pain from the oral tumour.
&gt; - The differential included infection, a salivary stone, and a tumour obstructing the duct.
&gt;
&gt; [!example] Swelling With Extensive Localised Bone Loss
&gt; A patient presented with a swelling that initially suggested infection.
&gt;
&gt; - The teeth were assessed for vitality, cracks, extensive restorations, and non-vitality.
&gt; - An OPG revealed a large amount of localised bone loss and a very mobile tooth.
&gt; - The lesion was ultimately diagnosed as lymphoma.
&gt; - A history of previous cancer was relevant to the assessment.
&gt;
&gt; [!example] Mucosal Melanoma
&gt; Mucosal melanoma was described as an extensive pigmented lesion involving the soft tissues.
&gt;
&gt; - The associated teeth may bleed easily and become mobile.
&gt; - Bone loss may occur if the melanoma invades the bone.
&gt; - A lesion involving the uvula may affect speech and soft-palate function, producing difficulty saying “ah” and a nasal quality to the voice.
</insert>
    </audio_inserts>
    <images>
      <img order="0" bbox="620,395,889,893" bbox_format="xyxy_norm_1000" bbox_origin="top_left" bbox_space="page" type="image" path="W3 Oral Cancer - Foo_figures/img_31c3260717e4b14e.webp"/>
    </images>
  </page>
  <page number="21">
    <text>Sites and incidence of oral carcinoma

Incidence of SCC differs between anatomical sites :
▶ Lower lip is most susceptible – 35%
▶ Lateral or ventral tongue – 25%
▶ Floor of mouth – 20%
▶ Soft palate - 15%
▶ Other sites - gingiva/alveolar ridge
and buccal mucosa (1-4%)

![](W3 Oral Cancer - Foo_figures/img_8b9222efe7d181bf.webp)</text>
    <formatted_text>Incidence of SCC differs between anatomical sites:

- Lower lip is most susceptible – 35%
- Lateral or ventral tongue – 25%
- Floor of mouth – 20%
- Soft palate – 15%
- Other sites – gingiva/alveolar ridge and buccal mucosa (1–4%)</formatted_text>
    <audio_inserts count="2">
      <insert confidence="1" anchor="- Soft palate – 15% - Other sites – gingiva/alveolar ridge and buccal mucosa (1–">
- ==Other areas requiring particular attention include the lingual sulcus, retromolar region, and tonsillar region.==</insert>
      <insert timestamp="00:26:20" confidence="10" anchor="Intraoral areas prone to development of SCC  Other intraoral sites">

&gt; [!note] Lecturer — Oral Cancer Sites
&gt; The lateral and ventral tongue were emphasised as key areas where oral cancer may hide.
&gt;
&gt; - The buccal mucosa is less commonly affected unless the patient chews and stores betel nut there.
&gt; - Approximately 30% of lip cancers present as a non-healing ulcer on the lip.
&gt; - Lip cancer is associated with sun exposure, including long-term outdoor work or activities without adequate sunscreen.
</insert>
    </audio_inserts>
    <images>
      <img order="0" bbox="512,460,840,856" bbox_format="xyxy_norm_1000" bbox_origin="top_left" bbox_space="page" type="image" path="W3 Oral Cancer - Foo_figures/img_8b9222efe7d181bf.webp"/>
    </images>
  </page>
  <page number="22">
    <text>Intraoral areas prone to development
of SCC



![Anterior floor of mouth](W3 Oral Cancer - Foo_figures/img_0738836c00e9e62c.webp)
![Lateral border of tongue](W3 Oral Cancer - Foo_figures/img_561d887b1d7126ed.webp)</text>
    <formatted_text>Intraoral areas prone to development of SCC</formatted_text>
    <images>
      <img order="0" bbox="100,463,462,888" bbox_format="xyxy_norm_1000" bbox_origin="top_left" bbox_space="page" type="photo" path="W3 Oral Cancer - Foo_figures/img_0738836c00e9e62c.webp" caption="Anterior floor of mouth">
        <description>Clinical photo: An intraoral close-up view of the anterior floor of the mouth, showing the mucosal tissue beneath the tongue and behind the lower front teeth.</description>
      </img>
      <img order="1" bbox="522,475,873,889" bbox_format="xyxy_norm_1000" bbox_origin="top_left" bbox_space="page" type="photo" path="W3 Oral Cancer - Foo_figures/img_561d887b1d7126ed.webp" caption="Lateral border of tongue">
        <description>A clinical photograph showing the lateral border of a tongue with a visible lesion. The area displays an irregular, erythematous patch with central ulceration and surrounding white tissue changes.</description>
      </img>
    </images>
  </page>
  <page number="23">
    <text>Intraoral areas prone to development
of SCC



![Tonsillar pillars](W3 Oral Cancer - Foo_figures/img_7ae9ac23e9657c34.webp)
![lateral soft palate](W3 Oral Cancer - Foo_figures/img_c502e094349a366d.webp)</text>
    <formatted_text>Intraoral areas prone to development of SCC</formatted_text>
    <images>
      <img order="0" bbox="94,471,434,876" bbox_format="xyxy_norm_1000" bbox_origin="top_left" bbox_space="page" type="image" path="W3 Oral Cancer - Foo_figures/img_7ae9ac23e9657c34.webp" caption="Tonsillar pillars"/>
      <img order="1" bbox="516,470,843,893" bbox_format="xyxy_norm_1000" bbox_origin="top_left" bbox_space="page" type="photo" path="W3 Oral Cancer - Foo_figures/img_c502e094349a366d.webp" caption="lateral soft palate">
        <description>Clinical photograph showing an intraoral view of the lateral soft palate. The image displays a lesion on the mucosal surface characterized by erythematous, irregular tissue with some whitish areas.</description>
      </img>
    </images>
  </page>
  <page number="24">
    <text>Other intraoral sites



![Gingiva/alveolar ridge](W3 Oral Cancer - Foo_figures/img_6a8b9f795710d6d2.webp)
![Buccal mucosa](W3 Oral Cancer - Foo_figures/img_950e17e917b7386c.webp)</text>
    <formatted_text>Other intraoral sites</formatted_text>
    <images>
      <img order="0" bbox="104,466,454,897" bbox_format="xyxy_norm_1000" bbox_origin="top_left" bbox_space="page" type="photo" path="W3 Oral Cancer - Foo_figures/img_6a8b9f795710d6d2.webp" caption="Gingiva/alveolar ridge">
        <description>Clinical photo showing the buccal aspect of mandibular molars with amalgam restorations and adjacent gingival tissue. The image illustrates the anatomical relationship between the tooth structure, restoration margins, and the alveolar ridge mucosa.</description>
      </img>
      <img order="1" bbox="520,473,876,896" bbox_format="xyxy_norm_1000" bbox_origin="top_left" bbox_space="page" type="photo" path="W3 Oral Cancer - Foo_figures/img_950e17e917b7386c.webp" caption="Buccal mucosa">
        <description>Clinical photo showing the buccal mucosa with a distinct, irregular white lesion (leukoplakia) on the inner cheek surface adjacent to the teeth.</description>
      </img>
    </images>
  </page>
  <page number="25">
    <text>THE UNIVERSITY OF
WESTERN
AUSTRALIA
Oral Health Centre
of Western Australia

Metastasis

*   Lymphatic spread
*   Tumour cells in lymph nodes extend into surrounding tissue (extra-capsular spread) or invade overlying skin
*   Enlarged, hard, fixed lymph nodes – ominous clinical signs
*   Oral cavity SCC metastasize to submandibular, superficial and deep cervical nodes
*   Beyond the regional lymph nodes, metastasize to the lungs</text>
    <formatted_text>- Lymphatic spread
- Tumour cells in lymph nodes extend into surrounding tissue (extra-capsular spread) or invade overlying skin
- Enlarged, hard, fixed lymph nodes – ominous clinical signs
- Oral cavity SCC metastasize to submandibular, superficial and deep cervical nodes
- Beyond the regional lymph nodes, metastasize to the lungs</formatted_text>
    <audio_inserts count="3">
      <insert timestamp="00:34:29" confidence="5" anchor="Beyond the regional lymph nodes, metastasize to the lungs">
- ==Oral cavity tumours commonly spread to the submandibular, sublingual, and jugular-chain lymph nodes.==
- ==A submandibular duct may become blocked when disease involves the submandibular or sublingual region.==
- ==A persistent neck lump lasting approximately two weeks or not resolving after review requires investigation.==</insert>
      <insert timestamp="00:35:00" confidence="4" anchor="Midjugular chain area (deep lateral cervical nodes): metastasis from any portion">
- ==Level 1 comprises the submental and submandibular regions, while levels 2, 3, and 4 lie along the jugular chain.==
- ==Level 5 was described as more commonly associated with ENT conditions.==</insert>
      <insert timestamp="00:36:34" confidence="4" anchor="Midjugular chain area (deep lateral cervical nodes): metastasis from any portion">

&gt; [!note] Lecturer — Neck Examination
&gt; The clinician should examine the neck from behind the patient rather than from the front.
&gt; 
&gt; - Check level 1 first because it is an early site of spread.
&gt; - Then examine levels 2, 3, and 4.
</insert>
    </audio_inserts>
  </page>
  <page number="26">
    <text>Upper jugular chain or
jugulodigastric area
(posterior auricular
nodes): metastasis from
nasopharynx

Posterior triangle
(posterior-triangle lymph
nodes): metastasis from
nasopharynx, posterior
scalp, ear, temporal bone,
or skull base

Lower jugular chain area
(supraclavicular nodes):
metastasis from thyroid,
pyriform sinuses, upper
esophagus; rarely, from
primary tumor below clavicle

Submandibular triangle
(submandibular group):
metastasis from anterior
two thirds of tongue, floor
of mouth, gums, mucosa
of cheek

Submental triangle
(submental nodes): rarely
involved early, except in
metastasis from cancer of lip

Midjugular chain area (deep
lateral cervical nodes): metastasis
from any portion of oral cavity,
pharynx, or larynx (especially
from growths in Waldeyer's
tonsillar ring [nasopharynx,
tonsil, base of tongue])

©D.Klemm '02
© 2002 DAVID KLEMM

![](W3 Oral Cancer - Foo_figures/img_318e54653ecaf05a.webp)</text>
    <formatted_text>- Upper jugular chain or jugulodigastric area (posterior auricular nodes): metastasis from nasopharynx
- Posterior triangle (posterior-triangle lymph nodes): metastasis from nasopharynx, posterior scalp, ear, temporal bone, or skull base
- Lower jugular chain area (supraclavicular nodes): metastasis from thyroid, pyriform sinuses, upper esophagus; rarely, from primary tumor below clavicle
- Submandibular triangle (submandibular group): metastasis from anterior two thirds of tongue, floor of mouth, gums, mucosa of cheek
- Submental triangle (submental nodes): rarely involved early, except in metastasis from cancer of lip
- Midjugular chain area (deep lateral cervical nodes): metastasis from any portion of oral cavity, pharynx, or larynx (especially from growths in Waldeyer's tonsillar ring [nasopharynx, tonsil, base of tongue])

*©D.Klemm '02 — © 2002 David Klemm*</formatted_text>
    <images>
      <img order="0" bbox="148,109,839,890" bbox_format="xyxy_norm_1000" bbox_origin="top_left" bbox_space="page" type="image" path="W3 Oral Cancer - Foo_figures/img_318e54653ecaf05a.webp"/>
    </images>
  </page>
  <page number="27">
    <text>THE UNIVERSITY OF
WESTERN
AUSTRALIA
Oral Health Centre
of Western Australia

# Investigation

*   Biopsy - removal of a small amount of tissue which is sent to a pathologist to determine if cancer cells are present
*   Radiographs – OPG and chest x-ray
*   Imaging - PET, CT and MRI scans to determine the location, stage and spread of cancer
*   An flexible nasal endoscope is used to examine the nose, sinuses, larynx and pharynx</text>
    <formatted_text>- Biopsy - removal of a small amount of tissue which is sent to a pathologist to determine if cancer cells are present
- Radiographs - OPG and chest x-ray
- Imaging - PET, CT and MRI scans to determine the location, stage and spread of cancer
- A flexible nasal endoscope is used to examine the nose, sinuses, larynx and pharynx</formatted_text>
    <audio_inserts count="4">
      <insert timestamp="00:37:55" confidence="5" anchor="- Biopsy - removal of a small amount of tissue which is sent to a pathologist to">
- ==Suspicious lesions require a definitive diagnosis through biopsy, with referral for biopsy or an incisional biopsy where appropriate.==
- ==An excisional biopsy removes the entire lesion, but suspicious oral cancers generally require a sample rather than removal of the whole lesion.==
- ==The biopsy should include abnormal tissue from the centre of the tumour; normal tissue is not essential if adequate abnormal tissue is obtained.==
- ==A punch biopsy can provide adequate depth for pathological assessment, with 2 mm and 6 mm punch biopsies described as producing the same result.==
- ==The pathologist is particularly concerned with the depth of invasion, including whether the basement membrane has been invaded.==
- ==The specimen bottle must be correctly labelled.==
- ==Relevant clinical information includes smoking and alcohol history, the presence of a non-healing ulcer, and the duration of the lesion.==</insert>
      <insert confidence="1" anchor="- Radiographs - OPG and chest x-ray">
- ==Other radiographs may include periapical radiographs.==</insert>
      <insert timestamp="00:39:31" confidence="3" anchor="- Imaging - PET, CT and MRI scans to determine the location, stage and spread of">
- ==Imaging is used to determine the size and extent of the tumour and whether adjacent areas, such as the nose or sinuses, are involved.==</insert>
      <insert timestamp="00:39:16" confidence="5" anchor="- A flexible nasal endoscope is used to examine the nose, sinuses, larynx and ph">

&gt; [!note] Lecturer — Biopsy Follow-Up
&gt; An inadequate biopsy may require further investigation.
&gt;
&gt; - Repeat biopsy may be required if the first biopsy does not provide enough tissue.
&gt; - A lesion that does not heal within two or three weeks, or that appears suspicious, should be referred promptly.
</insert>
    </audio_inserts>
  </page>
  <page number="28">
    <text>Clinical Staging of Carcinomas of Head and Neck (TNM)

*   Clinical staging is used to designate the extent of disease and to determine the most appropriate treatment for patient
*   Uniform staging system provides comparisons of results of types of treatment
*   T – primary tumour
*   N – regional lymph node
*   M – distant metastasis
*   Clinical staging helps predict treatment response and outcomes (prognosis)</text>
    <formatted_text>- Clinical staging is used to designate the extent of disease and to determine the most appropriate treatment for the patient
- Uniform staging system provides comparisons of results of types of treatment
- Clinical staging helps predict treatment response and outcomes (prognosis)

- T - primary tumour
- N - regional lymph node
- M - distant metastasis</formatted_text>
    <audio_inserts count="1">
      <insert timestamp="00:40:40" confidence="4" anchor="- Uniform staging system provides comparisons of results of types of treatment -">

&gt; [!note] Lecturer — Prognosis and Diagnosis
&gt; Staging is not completely foolproof but provides a better estimate of prognosis.
&gt;
&gt; - Earlier diagnosis generally means a smaller tumour.
&gt; - Earlier diagnosis is associated with better prognosis and better survival.
</insert>
    </audio_inserts>
  </page>
  <page number="29">
    <text>THE UNIVERSITY OF
WESTERN
AUSTRALIA
Oral Health Centre
of Western Australia

TNM staging

**T refers to maximum radial dimension of the tumour**

**N refers to the lymph node**

**M refers to metastasis**

| Primary tumor (T) | | Regional lymph nodes (N) | |
| :--- | :--- | :--- | :--- |
| **TX** | Primary tumor cannot be assessed | **NX** | Regional nodes cannot be assessed |
| **T0** | No evidence of primary tumor | **N0** | No regional lymph node metastasis |
| **Tis** | Carcinoma in situ | **N1** | Metastasis in a single ipsilateral lymph node, ≤ 3cm in greatest dimension |
| **T1** | Tumor ≤ 2cm in greatest dimension | **N2** | Metastasis in a single ipsilateral lymph node, &gt; 3cm ≤ 6cm in greatest dimension; or in multiple ipsilateral lymph nodes, none &gt; 6cm in greatest dimension or in bilateral or contralateral lymph nodes, none &gt;6cm in greatest dimension |
| **T2** | Tumor &gt; 2cm but ≤ 4cm in greatest dimension | **N2a** | Metastasis in a single ipsilateral lymph node &gt; 3cm but ≤ 6 cm in greatest dimension |
| **T3** | Tumor &gt; 4cm in greatest dimension | **N2b** | Metastases in multiple ipsilateral lymph nodes, none &gt; 6cm in greatest dimension |
| **T4** | Lip: Tumor invades through cortical bone, inferior alveolar nerve, floor of mouth, or skin of the face, i.e, chin or nose* | **N2c** | Metastases in bilateral or contralateral lymph nodes, none &gt; 6 cm in greatest dimension |
| **T4a** | Moderately advanced local disease* (lip) Tumor invades through the cortical bone, mouth, or skin of the face (i.e, chin or nose) (oral cavity) Tumor invades adjacent structures (eg. through the cortical bone [mandible or maxilla] into the deep [extrinsic] muscle of the tongue [genioglossus, hyoglossus, palatoglossus, and styloglossus], maxillary sinus, or skin of the face) | **N3** | Metastasis in a lymph node, &gt; 6cm in greatest dimension |
| **T4b** | Very advanced local disease Tumor infiltrates masticator space, pterygoid plates, or skull base and/or encases internal carotid artery | | Distant metastases (M) |
| | | **M0** | No distant metastases |
| | | **M1** | Distant metastasis |

*Superficial erosion alone of bone/tooth socket by gingival primary tumor is not sufficient to classify a tumor as T4.

![](W3 Oral Cancer - Foo_figures/img_0c2a21ff41e94aab.webp)</text>
    <formatted_text>- **T** refers to maximum radial dimension of the tumour
- **N** refers to the lymph node
- **M** refers to metastasis

#### Primary Tumor (T) and Regional Lymph Nodes (N)

| Primary tumor (T) | | Regional lymph nodes (N) | |
| :--- | :--- | :--- | :--- |
| **TX** | Primary tumor cannot be assessed | **NX** | Regional nodes cannot be assessed |
| **T0** | No evidence of primary tumor | **N0** | No regional lymph node metastasis |
| **Tis** | Carcinoma in situ | **N1** | Metastasis in a single ipsilateral lymph node, ≤ 3cm in greatest dimension |
| **T1** | Tumor ≤ 2cm in greatest dimension | **N2** | Metastasis in a single ipsilateral lymph node, &gt; 3cm ≤ 6cm in greatest dimension; or in multiple ipsilateral lymph nodes, none &gt; 6cm in greatest dimension or in bilateral or contralateral lymph nodes, none &gt; 6cm in greatest dimension |
| **T2** | Tumor &gt; 2cm but ≤ 4cm in greatest dimension | **N2a** | Metastasis in a single ipsilateral lymph node &gt; 3cm but ≤ 6cm in greatest dimension |
| **T3** | Tumor &gt; 4cm in greatest dimension | **N2b** | Metastases in multiple ipsilateral lymph nodes, none &gt; 6cm in greatest dimension |
| **T4** | Lip: Tumor invades through cortical bone, inferior alveolar nerve, floor of mouth, or skin of the face, i.e., chin or nose* | **N2c** | Metastases in bilateral or contralateral lymph nodes, none &gt; 6cm in greatest dimension |
| **T4a** | Moderately advanced local disease* (lip) Tumor invades through the cortical bone, mouth, or skin of the face (i.e., chin or nose) (oral cavity) Tumor invades adjacent structures (e.g., through the cortical bone [mandible or maxilla] into the deep [extrinsic] muscle of the tongue [genioglossus, hyoglossus, palatoglossus, and styloglossus], maxillary sinus, or skin of the face) | **N3** | Metastasis in a lymph node, &gt; 6cm in greatest dimension |
| **T4b** | Very advanced local disease Tumor infiltrates masticator space, pterygoid plates, or skull base and/or encases internal carotid artery | | Distant metastases (M) |
| | | **M0** | No distant metastases |
| | | **M1** | Distant metastasis |

\* Superficial erosion alone of bone/tooth socket by gingival primary tumor is not sufficient to classify a tumor as T4.</formatted_text>
    <audio_inserts count="1">
      <insert timestamp="00:43:03" confidence="7" anchor="* Superficial erosion alone of bone/tooth socket by gingival primary tumor is no">

&gt; [!note] Lecturer — Tumor and Node Assessment
&gt; The tumour must be considered in three dimensions rather than two.
&gt;
&gt; - For a lesion in the lingual sulcus, assessment must determine whether it has invaded the soft tissues, tongue, mandible, or nearby teeth.
&gt; - Lymph-node assessment is important because lymph nodes are among the first sites to which oral cancer spreads.
&gt; - The biopsy result may indicate cancer, insufficient or inadequate tissue, or no cancer.
&gt; - If the sample is inadequate, another biopsy may be required; if no cancer is identified, the patient may be monitored.
</insert>
    </audio_inserts>
    <images>
      <img order="0" bbox="461,187,912,872" bbox_format="xyxy_norm_1000" bbox_origin="top_left" bbox_space="page" type="table" path="W3 Oral Cancer - Foo_figures/img_0c2a21ff41e94aab.webp">
        <description>A two-column table detailing the TNM staging criteria for oral cancer, specifically listing the definitions for Primary tumor (T) and Regional lymph nodes (N). The left column outlines T categories from TX to T4b based on tumour size and invasion depth, while the right column defines N categories from NX to N3 based on lymph node involvement and metastasis.</description>
      </img>
    </images>
  </page>
  <page number="30">
    <text>THE UNIVERSITY OF
WESTERN
AUSTRALIA
Oral Health Centre
of Western Australia

# Management

*   Every patient with oral cancer should be presented at a Multidisciplinary Team Meeting (MDT)
*   This integrated team approach to healthcare in which medical and allied health professionals consider all relevant treatment options and collaboratively develop an individual treatment and care plan for each patient
*   The benefits of adopting a multidisciplinary approach include:
    *   improving patient care through developing an agreed treatment plan
    *   providing best practice through adopting evidence-based guidelines
    *   improving patient satisfaction with treatment
    *   improving the mental wellbeing of patients
    *   improving access to possible clinical trials of new therapies
    *   increasing the timeliness of appropriate consultations and surgery and a shorter timeframe from diagnosis to treatment
    *   increasing the access to timely supportive and palliative care
    *   streamlining pathways
    *   reducing duplication of services</text>
    <formatted_text>Every patient with oral cancer should be presented at a Multidisciplinary Team Meeting (MDT).

This is an integrated team approach to healthcare in which medical and allied health professionals consider all relevant treatment options and collaboratively develop an individual treatment and care plan for each patient.

#### Benefits of a Multidisciplinary Approach

- Improving patient care through developing an agreed treatment plan
- Providing best practice through adopting evidence-based guidelines
- Improving patient satisfaction with treatment
- Improving the mental wellbeing of patients
- Improving access to possible clinical trials of new therapies
- Increasing the timeliness of appropriate consultations and surgery, and a shorter timeframe from diagnosis to treatment
- Increasing the access to timely supportive and palliative care
- Streamlining pathways
- Reducing duplication of services</formatted_text>
    <audio_inserts count="2">
      <insert timestamp="00:42:38" confidence="6" anchor="This is an integrated team approach to healthcare in which medical and allied he">

&gt; [!note] Lecturer — Treatment Planning
&gt; Once cancer is confirmed, the patient is discussed by the multidisciplinary team. The team may include surgeons, dentists, pathologists, radiologists, general practitioners, and other relevant health professionals.
&gt;
&gt; - The team combines the expertise of different professionals to plan the most appropriate treatment.
&gt; - Oral cancer is commonly treated with surgery, potentially followed by radiotherapy when there are unfavourable features such as a poorly differentiated tumour, very close margins, or spread to lymph nodes.
&gt; - Chemotherapy or radiotherapy may also be used when a large tumour is not operable.
</insert>
      <insert timestamp="00:43:51" confidence="6" anchor="Reducing duplication of services">
- ==A clinical trial may provide additional time for a patient with an inoperable tumour even when it is not expected to cure the patient==
- ==Social-service support may be needed when treatment and recovery prevent the patient from working==
- ==The general practitioner may help coordinate care, including pain control==</insert>
    </audio_inserts>
  </page>
  <page number="31">
    <text>THE UNIVERSITY OF
WESTERN
AUSTRALIA
Oral Health Centre
of Western Australia

Treatment team

*   GP (General Practitioner)- looks after patient’s general health and works with specialists to coordinate treatment
*   Head and neck surgeon- diagnoses and treats cancers of the head and neck
*   **Dentist- evaluates and treats the mouth and teeth (before, during and after treatment)**
*   Radiation oncologist- prescribes and coordinates radiation therapy treatment
*   Medical oncologist- prescribes and coordinates the course of chemotherapy
*   Cancer nurses- assist with treatment and provide information and support throughout treatment
*   Dietitian- recommends an eating plan to follow during treatment and recovery
*   Speech pathologist- helps with swallowing and communication difficulties during and after treatment
*   Other allied health professionals- such as social workers, pharmacists and counsellors.</text>
    <formatted_text>- GP (General Practitioner) — looks after the patient's general health and works with specialists to coordinate treatment
- Head and neck surgeon — diagnoses and treats cancers of the head and neck
- Dentist — evaluates and treats the mouth and teeth (before, during and after treatment)
- Radiation oncologist — prescribes and coordinates radiation therapy treatment
- Medical oncologist — prescribes and coordinates the course of chemotherapy
- Cancer nurses — assist with treatment and provide information and support throughout treatment
- Dietitian — recommends an eating plan to follow during treatment and recovery
- Speech pathologist — helps with swallowing and communication difficulties during and after treatment
- Other allied health professionals — such as social workers, pharmacists and counsellors</formatted_text>
    <audio_inserts count="1">
      <insert timestamp="00:53:38" confidence="5" anchor="Other allied health professionals — such as social workers, pharmacists and coun">

&gt; [!note] Lecturer — Team Considerations
&gt; The treatment team considers the tumour site, tumour size, lymph-node involvement, margins, possible spread, treatment goals, and quality of life. Treatment goals may differ between patients: some may prioritise minimal intervention, while others may prefer more extensive treatment to preserve function and maintain oral health.
</insert>
    </audio_inserts>
  </page>
  <page number="32">
    <text># Pre radiotherapy dental assessment

**Referral to Oral Health Centre of WA**  
Department of Oral Medicine and Oral Pathology  
Pre-Chemotherapy / Pre-Radiation Therapy Dental Evaluation

Patient Details: [Redacted]

Diagnosis: Hypopharyngeal SCC, has had surgery

Proposed treatment: Post-operative radiotherapy (66Gy/33#)

Please advise of extent of radiation therapy field (please also mark teeth to be included on the chart below)

Dose of radiation to be administered (Gy) 66Gy/33#

| Upper Teeth: | | | | |
| :--- | :--- | :---: | :--- | :--- |
| 40 | Central Incisor&lt;br&gt;Lateral Incisor&lt;br&gt;Canine (Cuspid)&lt;br&gt;First Premolar (first bicuspid)&lt;br&gt;Second Premolar (second bicuspid) |  | Central Incisor&lt;br&gt;Lateral Incisor&lt;br&gt;Canine (Cuspid)&lt;br&gt;First Premolar (first bicuspid)&lt;br&gt;Second Premolar (second bicuspid) | 40 |
| 66 | First Molar&lt;br&gt;Second Molar&lt;br&gt;Third Molar (wisdom tooth) | | First Molar&lt;br&gt;Second Molar&lt;br&gt;Third Molar (wisdom tooth) | 66 |

| Lower Teeth: | | | | |
| :--- | :--- | :---: | :--- | :--- |
| 66 | Third Molar (wisdom tooth)&lt;br&gt;Second Molar&lt;br&gt;First Molar |  | Third Molar (wisdom tooth)&lt;br&gt;Second Molar&lt;br&gt;First Molar | 66 |
| 40 | Second Premolar (second bicuspid)&lt;br&gt;First Premolar (first bicuspid)&lt;br&gt;Canine (Cuspid)&lt;br&gt;Lateral Incisor&lt;br&gt;Central Incisor | | Second Premolar (second bicuspid)&lt;br&gt;First Premolar (first bicuspid)&lt;br&gt;Canine (Cuspid)&lt;br&gt;Lateral Incisor&lt;br&gt;Central Incisor | 40 |

**Right** &amp;emsp;&amp;emsp;&amp;emsp;&amp;emsp;&amp;emsp;&amp;emsp;&amp;emsp;&amp;emsp;&amp;emsp;&amp;emsp;&amp;emsp;&amp;emsp;&amp;emsp;&amp;emsp;&amp;emsp;&amp;emsp;&amp;emsp;&amp;emsp;&amp;emsp;&amp;emsp;&amp;emsp;&amp;emsp;&amp;emsp;&amp;emsp;&amp;emsp;&amp;emsp;&amp;emsp;&amp;emsp;&amp;emsp;&amp;emsp;&amp;emsp;&amp;emsp;&amp;emsp;&amp;emsp; **Left**

![](W3 Oral Cancer - Foo_figures/img_cf4549c26fec49a4.webp)</text>
    <formatted_text>#### Referral to Oral Health Centre of WA

Department of Oral Medicine and Oral Pathology — Pre-Chemotherapy / Pre-Radiation Therapy Dental Evaluation

- Diagnosis: Hypopharyngeal SCC, has had surgery
- Proposed treatment: Post-operative radiotherapy (66Gy/33#)

Please advise of extent of radiation therapy field (please also mark teeth to be included on the chart below).

Dose of radiation to be administered (Gy): 66Gy/33#

#### Dental Chart

**Upper Teeth**

| | | | |
| :--- | :---: | :--- | :---: |
| Central Incisor / Lateral Incisor / Canine (Cuspid) / First Premolar (first bicuspid) / Second Premolar (second bicuspid) | 40 | Central Incisor / Lateral Incisor / Canine (Cuspid) / First Premolar (first bicuspid) / Second Premolar (second bicuspid) | 40 |
| First Molar / Second Molar / Third Molar (wisdom tooth) | 66 | First Molar / Second Molar / Third Molar (wisdom tooth) | 66 |

**Lower Teeth**

| | | | |
| :--- | :---: | :--- | :---: |
| Third Molar (wisdom tooth) / Second Molar / First Molar | 66 | Third Molar (wisdom tooth) / Second Molar / First Molar | 66 |
| Second Premolar (second bicuspid) / First Premolar (first bicuspid) / Canine (Cuspid) / Lateral Incisor / Central Incisor | 40 | Second Premolar (second bicuspid) / First Premolar (first bicuspid) / Canine (Cuspid) / Lateral Incisor / Central Incisor | 40 |

**Right** — **Left**</formatted_text>
    <audio_inserts count="2">
      <insert timestamp="00:52:14" confidence="4" anchor="Please advise of extent of radiation therapy field (please also mark teeth to be">

&gt; [!note] Lecturer — Pre-Radiotherapy Extractions
&gt; Before radiotherapy, teeth in the radiation field with a poor prognosis may need to be extracted. A 7 mm periodontal pocket, extensive restoration, or significant periodontal involvement may suggest that a tooth will not do well.
&gt;
&gt; - The lecturer identified approximately 55 Gy as an important level: at lower doses teeth may sometimes be monitored, whereas at 55 Gy or more extraction may be considered if there is doubt about prognosis.
&gt; - The aim is to avoid extractions after radiotherapy whenever possible because radiotherapy reduces the healing capacity of the mandible and maxilla.
</insert>
      <insert timestamp="00:47:56" confidence="7" anchor="Dose of radiation to be administered (Gy): 66Gy/33#">

&gt; [!note] Lecturer — Radiation Field
&gt; The radiation field should be identified before treatment. If the cancer is on one side of the tongue, the teeth on that side, particularly the molars, may receive a higher radiation dose.
</insert>
    </audio_inserts>
    <images>
      <img order="0" bbox="540,284,694,390" bbox_format="xyxy_norm_1000" bbox_origin="top_left" bbox_space="page" type="image" path="W3 Oral Cancer - Foo_figures/img_cf4549c26fec49a4.webp"/>
    </images>
  </page>
  <page number="33">
    <text>Pre-treatment dental assessment

| | |
| :--- | :--- |
| **Cancer** | **Diagnosis, prognosis**&lt;br&gt;**Treatment modality**&lt;br&gt;**Radiation fields**&lt;br&gt;**Start dates** |
| Patient | Treatment goals&lt;br&gt;Socio-economic factors&lt;br&gt;Quality of life&lt;br&gt;Motivation |
| Oral Health | Dental history&lt;br&gt;Oral hygiene&lt;br&gt;Maintenance ability |
| Dentition | State of dentition&lt;br&gt;Existing oral health&lt;br&gt;Future rehabilitation potential and considerations |

![](W3 Oral Cancer - Foo_figures/img_be335d295b16adce.webp)</text>
    <formatted_text>| | |
| :--- | :--- |
| **Cancer** | Diagnosis, prognosis — Treatment modality — Radiation fields — Start dates |
| **Patient** | Treatment goals — Socio-economic factors — Quality of life — Motivation |
| **Oral Health** | Dental history — Oral hygiene — Maintenance ability |
| **Dentition** | State of dentition — Existing oral health — Future rehabilitation potential and considerations |</formatted_text>
    <images>
      <img order="0" bbox="114,266,930,928" bbox_format="xyxy_norm_1000" bbox_origin="top_left" bbox_space="page" type="table" path="W3 Oral Cancer - Foo_figures/img_be335d295b16adce.webp">
        <description>A two-column table listing four assessment categories in the left column (Cancer, Patient, Oral Health, Dentition) and corresponding detailed factors in the right column.</description>
      </img>
    </images>
  </page>
  <page number="34">
    <text>During radiotherapy and chemotherapy

**Changes in taste**

**Oral hygiene maintenance-mucositis**

**Systemic considerations-pancytopenia, opportunistic infections**</text>
    <formatted_text>- Changes in taste
- Oral hygiene maintenance — mucositis
- Systemic considerations — pancytopenia, opportunistic infections</formatted_text>
    <audio_inserts count="1">
      <insert timestamp="00:54:49" confidence="10" anchor="Systemic considerations — pancytopenia, opportunistic infections">

&gt; [!note] Lecturer — Treatment Complications
&gt; Chemotherapy and radiotherapy may cause pancytopenia, with reductions in platelets, red blood cells, and white blood cells, leaving patients more prone to infections such as oral thrush. Pseudomembranous thrush may appear as white plaques that can be wiped away, leaving an erythematous surface.
&gt;
&gt; - Treatment may include antifungal medication and instruction on denture cleaning.
&gt; - After surgery, the bite may be altered and the patient may have difficulty swallowing or increased drooling.
&gt; - Dental care may include caries treatment, root canal treatment, staining and polishing, oral-hygiene instruction, fluoride use, dry-mouth management, and denture hygiene.
</insert>
    </audio_inserts>
  </page>
  <page number="35">
    <text>Post treatment dental management

Regular review and maintenance


![Motivation](W3 Oral Cancer - Foo_figures/img_f45ba2ab62a8ba6f.webp)</text>
    <formatted_text>Regular review and maintenance.</formatted_text>
    <images>
      <img order="0" bbox="670,355,807,634" bbox_format="xyxy_norm_1000" bbox_origin="top_left" bbox_space="page" type="image" path="W3 Oral Cancer - Foo_figures/img_f45ba2ab62a8ba6f.webp" caption="Motivation"/>
    </images>
  </page>
  <page number="36">
    <text>Initially 3 monthly review for caries and periodontal management

Once oral condition stabilize, 6 monthly recalls – look out for mucosal changes, xerostomia, candidiasis, changes in occlusion

Fluoride at each recall – Neutrafluor 5000 toothpaste and fluoride varnish</text>
    <formatted_text>- Initially 3-monthly review for caries and periodontal management
- Once oral condition stabilizes, 6-monthly recalls — look out for mucosal changes, xerostomia, candidiasis, changes in occlusion
- Fluoride at each recall — Neutrafluor 5000 toothpaste and fluoride varnish</formatted_text>
    <audio_inserts count="2">
      <insert timestamp="00:56:57" confidence="2" anchor="Fluoride at each recall — Neutrafluor 5000 toothpaste and fluoride varnish">

&gt; [!note] Lecturer — Ongoing Support
&gt; The clinician should continue supporting the patient after cancer treatment rather than discontinuing care. The patient’s life and oral cavity may remain permanently changed, with possible altered bite, dry mouth, increased caries risk, recurrent infections, difficulty cleaning dentures, and changes in oral function.
&gt;
&gt; - Saliva replacement and frequent drinking may be required.
&gt; - Patients may need longer appointments and more frequent dental review.
</insert>
      <insert timestamp="01:00:08" confidence="5" anchor="Reconstruction With Free Tissue Transfer SCC right mandible Resection and recons">

&gt; [!note] Lecturer — Free Tissue Transfer
&gt; Reconstruction should replace like with like, with soft-tissue defects replaced by soft tissue and bone defects requiring bone and soft-tissue reconstruction.
&gt;
&gt; - A soft-tissue defect involving the tongue or ventral tongue may be reconstructed with tissue from the thigh, leg or arm.
&gt; - The transferred tissue includes an artery and vein that must be connected to vessels in the neck.
&gt; - A skin graft may not survive in a large defect because it may not receive enough blood supply.
&gt; - If the tumour has eroded the mandible, the affected bone is resected and replaced with bone from another site, such as the leg.
&gt; - A reconstruction plate may hold the transferred bone in position.
&gt; - Preserving occlusion and the patient’s ability to function are important considerations.
&gt; - The dentist’s role includes maintaining the remaining teeth and motivating the patient during and after treatment.
</insert>
    </audio_inserts>
  </page>
  <page number="37">
    <text>THE UNIVERSITY OF
WESTERN
AUSTRALIA
Oral Health Centre
of Western Australia

Treatment

*   Intent of treatment - Curative versus palliative
*   Surgery – primary modality of treatment for oral cancer - removes the tumour (ablation) and lymph nodes (neck dissection)
    Adjuvant radiotherapy after surgery depends on the pathological staging of the tumour, surgical margins and nodal status for patients at high risk of locoregional recurrence)
*   Radiotherapy- used on its own to treat for organ presercation e.g. oropharyngeal cancers. Usually concurrently with chemotherapy
*   Chemotherapy – Concurrent or adjuvant chemoradiation has now become the standard of care in locally advanced head and neck squamous cell carcinoma</text>
    <formatted_text>- Intent of treatment — curative versus palliative
- Surgery — primary modality of treatment for oral cancer; removes the tumour (ablation) and lymph nodes (neck dissection). Adjuvant radiotherapy after surgery depends on the pathological staging of the tumour, surgical margins and nodal status (for patients at high risk of locoregional recurrence)
- Radiotherapy — used on its own to treat for organ preservation, e.g. oropharyngeal cancers. Usually concurrently with chemotherapy
- Chemotherapy — concurrent or adjuvant chemoradiation has now become the standard of care in locally advanced head and neck squamous cell carcinoma</formatted_text>
    <audio_inserts count="1">
      <insert timestamp="00:50:04" confidence="7" anchor="- Chemotherapy — concurrent or adjuvant chemoradiation has now become the standa">
- ==Treatment depends on the size and extent of the tumour and the presence of unfavourable features.==
- ==Chemotherapy may be palliative, providing additional time rather than curing the cancer.==
- ==The aim is also to assess whether microscopic spread has occurred in the lymph nodes and whether radiotherapy is required.==</insert>
    </audio_inserts>
  </page>
  <page number="38">
    <text>Surgery for oral cancer

*   Surgery to remove the tumour (ablation) and lymph nodes (neck dissection)
*   Adjuvant radiotherapy after surgery depends on the pathological staging of the tumour, surgical margins and nodal status
*   The goal of the surgery is :
    *   to remove the tumour with a 5mm microscopic margin of normal tissue around the tumour
    *   Plus management of the cervical nodes (neck dissection)
    *   Plus reconstructive surgery to restore speech, swallow and mastication</text>
    <formatted_text>- Surgery to remove the tumour (ablation) and lymph nodes (neck dissection)
- Adjuvant radiotherapy after surgery depends on the pathological staging of the tumour, surgical margins and nodal status

The goal of the surgery is:

1. To remove the tumour with a 5 mm microscopic margin of normal tissue around the tumour
2. Plus management of the cervical nodes (neck dissection)
3. Plus reconstructive surgery to restore speech, swallow and mastication</formatted_text>
    <audio_inserts count="1">
      <insert timestamp="00:58:20" confidence="5" anchor="3. Plus reconstructive surgery to restore speech, swallow and mastication">

- ==Surgery must account for the three-dimensional extent of the tumour, including involvement of the tongue, floor of the mouth, mandible, teeth and other adjacent structures.==
- ==Lymph nodes at levels 1, 2, 3 and 4 may be removed or sampled because they are possible sites of spread.==
&gt; [!note] Lecturer — Defect Closure
&gt; Simply closing a large defect by pulling surrounding tissues together may not restore adequate function.
</insert>
    </audio_inserts>
  </page>
  <page number="39">
    <text>THE UNIVERSITY OF
WESTERN
AUSTRALIA
Oral Health Centre
of Western Australia

Cervical lymph
nodes levels I - VI

**Neck dissection**
refers to removal of
cervical lymph
nodes at different
levels

Hyoid Bone
Thyroid
Cartilage
Cricothyroid
membrane
I
II
III
VI
IV
V
Sternocleido-
mastoid
muscle

![](W3 Oral Cancer - Foo_figures/img_01963782df60708e.webp)</text>
    <formatted_text>**Neck dissection** refers to removal of cervical lymph nodes at different levels.

*Cervical lymph nodes levels I–VI.* Anatomical landmarks shown: hyoid bone, thyroid cartilage, cricothyroid membrane, sternocleidomastoid muscle; node levels labelled I, II, III, IV, V, VI.</formatted_text>
    <images>
      <img order="0" bbox="472,253,929,895" bbox_format="xyxy_norm_1000" bbox_origin="top_left" bbox_space="page" type="diagram" path="W3 Oral Cancer - Foo_figures/img_01963782df60708e.webp">
        <description>A labelled anatomical diagram of the human neck in lateral profile, illustrating the levels of cervical lymph nodes relevant to neck dissection. The figure delineates zones I through VI using dashed lines and identifies key landmarks including the Hyoid Bone, Thyroid Cartilage, Cricothyroid membrane, and Sternocleidomastoid muscle.</description>
      </img>
    </images>
  </page>
  <page number="40">
    <text>THE UNIVERSITY OF
WESTERN
AUSTRALIA

Oral Health Centre
of Western Australia

Surgery for oral
cancer

**Partial**
resection of
tongue and
neck
dissection

![](W3 Oral Cancer - Foo_figures/img_ccf87c76efacfde1.webp)</text>
    <formatted_text>*Partial resection of tongue and neck dissection.*</formatted_text>
    <audio_inserts count="1">
      <insert timestamp="00:34:47" confidence="3" anchor="Partial resection of tongue and neck dissection.">
- ==Regional lymph nodes are removed or sampled to determine whether microscopic metastasis has occurred.==
- ==For oral cavity tumours, the relevant nodal levels are 1, 2, 3 and 4, and the findings help determine whether additional radiotherapy is required.==</insert>
    </audio_inserts>
    <images>
      <img order="0" bbox="476,166,810,921" bbox_format="xyxy_norm_1000" bbox_origin="top_left" bbox_space="page" type="photo" path="W3 Oral Cancer - Foo_figures/img_ccf87c76efacfde1.webp">
        <description>Clinical photograph showing an intraoperative view of a partial glossectomy and neck dissection. The image displays the resected tongue specimen held by surgical instruments, exposing the underlying musculature and vascular structures of the floor of the mouth and neck.</description>
      </img>
    </images>
  </page>
  <page number="41">
    <text>Reconstruction with free tissue transfer

![](W3 Oral Cancer - Foo_figures/img_06149a595f0cab34.webp)
![](W3 Oral Cancer - Foo_figures/img_f074fdf48e990b56.webp)</text>
    <formatted_text>Reconstruction with free tissue transfer</formatted_text>
    <images>
      <img order="0" bbox="74,387,484,828" bbox_format="xyxy_norm_1000" bbox_origin="top_left" bbox_space="page" type="photo" path="W3 Oral Cancer - Foo_figures/img_06149a595f0cab34.webp">
        <description>Clinical photograph showing the harvest of a free tissue flap from the lateral aspect of a patient's thigh. The image displays an elliptical area where the skin paddle has been incised and elevated, exposing the underlying subcutaneous fat and muscle bed, alongside a larger proximal incision revealing deeper tissue layers.</description>
      </img>
      <img order="1" bbox="514,376,898,876" bbox_format="xyxy_norm_1000" bbox_origin="top_left" bbox_space="page" type="photo" path="W3 Oral Cancer - Foo_figures/img_f074fdf48e990b56.webp">
        <description>Clinical photograph showing an intraoral view of a reconstructed tongue using free tissue transfer. The image displays a bulky, pale flap sutured to the native reddish tongue tissue within the oral cavity, surrounded by teeth and lips.</description>
      </img>
    </images>
  </page>
  <page number="42">
    <text>THE UNIVERSITY OF
WESTERN
AUSTRALIA
Oral Health Centre
of Western Australia
SEEK WISDOM

SCC right mandible

![](W3 Oral Cancer - Foo_figures/img_cbece681b57f489a.webp)
![](W3 Oral Cancer - Foo_figures/img_e0ec36b93208a1b1.webp)</text>
    <formatted_text>*SCC right mandible*</formatted_text>
    <images>
      <img order="0" bbox="94,393,468,833" bbox_format="xyxy_norm_1000" bbox_origin="top_left" bbox_space="page" type="photo" path="W3 Oral Cancer - Foo_figures/img_cbece681b57f489a.webp">
        <description>Clinical intraoral photograph showing the posterior mandibular region with visible teeth and gingival tissue. The image displays a lesion on the alveolar mucosa, appearing as an irregular area of mixed redness and whitish texture adjacent to the molars.</description>
      </img>
      <img order="1" bbox="492,409,919,823" bbox_format="xyxy_norm_1000" bbox_origin="top_left" bbox_space="page" type="photo" path="W3 Oral Cancer - Foo_figures/img_e0ec36b93208a1b1.webp">
        <description>Clinical photo: A panoramic dental radiograph displaying the maxilla and mandible, showing multiple teeth with restorations and significant bone loss. The image illustrates a large radiolucent lesion in the right mandibular region (viewer's left), consistent with the slide context of squamous cell carcinoma.</description>
      </img>
    </images>
  </page>
  <page number="43">
    <text>Resection and reconstruction with free tissue transfer

![](W3 Oral Cancer - Foo_figures/img_9a18f6096f0c7680.webp)
![](W3 Oral Cancer - Foo_figures/img_e347c955e2824afd.webp)</text>
    <formatted_text>Resection and reconstruction with free tissue transfer</formatted_text>
    <images>
      <img order="0" bbox="116,322,339,931" bbox_format="xyxy_norm_1000" bbox_origin="top_left" bbox_space="page" type="photo" path="W3 Oral Cancer - Foo_figures/img_9a18f6096f0c7680.webp">
        <description>Clinical photo: Intraoperative view of an open surgical site with exposed tissue, held apart by metal retractors while gloved hands manipulate instruments within the wound bed.</description>
      </img>
      <img order="1" bbox="450,420,894,866" bbox_format="xyxy_norm_1000" bbox_origin="top_left" bbox_space="page" type="photo" path="W3 Oral Cancer - Foo_figures/img_e347c955e2824afd.webp">
        <description>This is a panoramic radiograph showing the post-operative reconstruction of the right mandible. A large metallic reconstruction plate with multiple screws bridges a segmental defect in the lower jaw, securing the remaining bone segments together.</description>
      </img>
    </images>
  </page>
  <page number="44">
    <text>THE UNIVERSITY OF
WESTERN
AUSTRALIA
Oral Health Centre
of Western Australia

## Oral cancer

*   There is currently no national screening program for mouth cancer available in Australia
*   Dentists routinely use visual examination to check for signs for mouth cancer and early detection
*   Dentists play a role in prevention and counselling patients</text>
    <formatted_text>There is currently no national screening program for mouth cancer available in Australia.

- Dentists routinely use visual examination to check for signs of mouth cancer and early detection
- Dentists play a role in prevention and counselling patients</formatted_text>
  </page>
  <page number="45">
    <text>THE UNIVERSITY OF
WESTERN
AUSTRALIA

Oral Health Centre
of Western Australia

“ Early identification of oral cancers leads to improved treatment options for patients ”

**SYMPTOMS OF ORAL CANCER**

▪ White or red or speckled lesions
▪ Lesions or ulcers on the gingiva, palate, tongue, oral mucosa or lip that do not heal in 14 days
▪ Cervical lymphadenopathy
▪ Difficulty swallowing
▪ Unusual bleeding or pain or numbness in the mouth
▪ Mobile teeth or swelling of the jaw
▪ Changes in speech
▪ Unexplained weight loss</text>
    <formatted_text>&gt; &quot;Early identification of oral cancers leads to improved treatment options for patients&quot;

#### Symptoms of Oral Cancer

- White or red or speckled lesions
- Lesions or ulcers on the gingiva, palate, tongue, oral mucosa or lip that do not heal in 14 days
- Cervical lymphadenopathy
- Difficulty swallowing
- Unusual bleeding or pain or numbness in the mouth
- Mobile teeth or swelling of the jaw
- Changes in speech
- Unexplained weight loss</formatted_text>
    <audio_inserts count="2">
      <insert timestamp="00:10:11" confidence="4" anchor="&gt; &quot;Early identification of oral cancers leads to improved treatment options for ">

&gt; [!note] Lecturer — Clinical Recognition
&gt; The dentist may be the first clinician to identify oral cancer, but is not expected to make the definitive diagnosis.
&gt;
&gt; - The clinician should ==recognise unusual symptoms, maintain an index of suspicion, and refer for biopsy or perform an appropriate incisional biopsy==.
&gt; - Early identification improves prognosis and survival.
</insert>
      <insert timestamp="01:03:46" confidence="7" anchor="- Unexplained weight loss">
- ==An indurated lesion==
- ==Localised bone loss==
- ==Localised bone loss with a non-healing ulcer==
- ==An unusual lesion in a smoker and drinker==
- ==A persistent neck lump with no dental cause==
- ==Unexplained lip or facial numbness==
- ==A lesion that does not heal within two or three weeks should be investigated or referred==</insert>
    </audio_inserts>
  </page>
  <page number="46">
    <text>Visual
examination

Lips
Anterior 2/3 of the tongue
Gingiva
Buccal mucosa
Floor of the mouth and
ventral tongue
Hard palate and soft palate

The 8-Step
Oral Cancer Screening

A
Mucosa
Gingiva

B
Lip

C
Buccal
mucosa
Posterior
gingiva

D
Vestibule
Anterior
gingiva
Mucosa

E
Hard
palate

F
Tonsillar
area
Soft palate

G
Ventral surface
of tongue
Floor of
mouth

H
Lateral border
of tongue

![](W3 Oral Cancer - Foo_figures/img_860d07cbe2c1d54e.webp)
![](W3 Oral Cancer - Foo_figures/img_052a081a3a676bba.webp)</text>
    <formatted_text>#### The 8-Step Oral Cancer Screening — Visual Examination

Areas examined:

- Lips
- Anterior 2/3 of the tongue
- Gingiva
- Buccal mucosa
- Floor of the mouth and ventral tongue
- Hard palate and soft palate

Screening steps:

- **A** — Mucosa, Gingiva
- **B** — Lip
- **C** — Buccal mucosa, Posterior gingiva
- **D** — Vestibule, Anterior gingiva, Mucosa
- **E** — Hard palate
- **F** — Tonsillar area, Soft palate
- **G** — Ventral surface of tongue, Floor of mouth
- **H** — Lateral border of tongue</formatted_text>
    <audio_inserts count="1">
      <insert timestamp="01:04:28" confidence="6" anchor="- **H** — Lateral border of tongue">

&gt; [!note] Lecturer — Examination Method
&gt; The examination should be carried out systematically at every appointment so that important sites are not missed.
&gt;
&gt; - The sequence may begin with the lips or place the lips later in the examination, provided all areas are assessed.
&gt; - Additional areas include the sulci, maxilla, mandible, posterior lateral tongue, lingual sulcus, ventral surface of the tongue, floor of the mouth, palate, gingiva, and hard and soft palate.
&gt; - The lingual sulcus must be examined carefully because oral cancer commonly hides there, and the underside of the tongue is particularly important.
&gt; - The clinician should decide whether a lesion is confined to soft tissue or has extended into the mandible.
</insert>
    </audio_inserts>
    <images>
      <img order="0" bbox="454,422,657,910" bbox_format="xyxy_norm_1000" bbox_origin="top_left" bbox_space="page" type="figure" path="W3 Oral Cancer - Foo_figures/img_860d07cbe2c1d54e.webp">
        <description>A composite image showing four clinical illustrations of the oral cavity, labeled A, B, E, and F. Each panel depicts a specific examination area with pointers identifying anatomical structures: Panel A shows the upper gingiva and mucosa; Panel B displays the lip; Panel E illustrates the hard palate; and Panel F highlights the tonsillar area and soft palate.</description>
      </img>
      <img order="1" bbox="668,425,874,908" bbox_format="xyxy_norm_1000" bbox_origin="top_left" bbox_space="page" type="image" path="W3 Oral Cancer - Foo_figures/img_052a081a3a676bba.webp"/>
    </images>
  </page>
  <page number="47">
    <text>THE UNIVERSITY OF
WESTERN
AUSTRALIA
SEEK WISDOM

Oral Health Centre
of Western Australia

Prevention

*   Around 2/3 of mouth cancers in Australia are caused by smoking
*   Around 1/3 are caused by excess alcohol consumption
*   Synergistic effect of smoking and alcohol consumption
*   Quitting smoking and moderating alcohol consumption will significantly reduce risk of developing mouth cancer
*   Cancers of the lip are commonly associated with UV exposure, so sun protection is important

1 SERVING
AMOUNT LEFTOVER
2 SERVINGS
WINE FOLLY

![No smoking sign](W3 Oral Cancer - Foo_figures/img_6451c0372bec7d2d.webp)
![1 SERVING AMOUNT LEFTOVER 2 SERVINGS WINE FOLLY](W3 Oral Cancer - Foo_figures/img_484e078c134441bb.webp)
![](W3 Oral Cancer - Foo_figures/img_82901426ed5da907.webp)</text>
    <formatted_text>- Around 2/3 of mouth cancers in Australia are caused by smoking
- Around 1/3 are caused by excess alcohol consumption
- Synergistic effect of smoking and alcohol consumption
- Quitting smoking and moderating alcohol consumption will significantly reduce risk of developing mouth cancer
- Cancers of the lip are commonly associated with UV exposure, so sun protection is important</formatted_text>
    <audio_inserts count="1">
      <insert timestamp="00:26:20" confidence="5" anchor="- Cancers of the lip are commonly associated with UV exposure, so sun protection">
- ==Prevention and early detection depend on recognising major lifestyle risk factors, identifying suspicious lesions, examining high-risk sites systematically, and referring promptly for biopsy or further investigation.==
- ==Patients who chew betel nut should be considered at increased risk, particularly for buccal mucosal cancer.==
- ==Ongoing oral care is important for patients before, during, and after cancer treatment.==</insert>
    </audio_inserts>
    <images>
      <img order="0" bbox="460,186,725,502" bbox_format="xyxy_norm_1000" bbox_origin="top_left" bbox_space="page" type="image" path="W3 Oral Cancer - Foo_figures/img_6451c0372bec7d2d.webp" caption="No smoking sign"/>
      <img order="1" bbox="464,551,736,896" bbox_format="xyxy_norm_1000" bbox_origin="top_left" bbox_space="page" type="image" path="W3 Oral Cancer - Foo_figures/img_484e078c134441bb.webp" caption="1 SERVING AMOUNT LEFTOVER 2 SERVINGS WINE FOLLY"/>
      <img order="2" bbox="829,269,874,613" bbox_format="xyxy_norm_1000" bbox_origin="top_left" bbox_space="page" type="photo" path="W3 Oral Cancer - Foo_figures/img_82901426ed5da907.webp">
        <description>A product photo of a tube of Cancer Council Ultra Sunscreen Lip Balm. The packaging displays the brand logo, an SPF 50+ rating, and text indicating it provides broad spectrum protection.</description>
      </img>
    </images>
  </page>
  <page number="48" origin="cases">
    <text>## Case: Lower anterior non-healing ulcer and localized bone loss

### Question

**Scenario:** A patient presents with a non-healing ulcer in the lower anterior region, a loose bridge, and food impaction.

**What's shown:** A panoramic radiograph (OPG) and an intraoral clinical photograph of the lower anterior region.

**Consider:** What should be considered when bone loss and a non-healing ulcer are localized to one specific area rather than being generalized?


### Answer

**Observations:**
- Generalized bone loss, but with more severe, localized bone loss around the lower anteriors (specifically noted around teeth 4 and 2).
- A non-healing ulcer in the lower anterior region.
- A loose bridge and food impaction in the affected area.

**Reasoning:** While bone loss is most commonly due to periodontal disease, localized bone loss combined with a non-healing ulcer in a specific area should prompt lateral thinking. It is important to consider other causes, such as a malignancy or local infection, rather than assuming it is solely periodontal disease.

**Outcome:** The area was investigated and the findings turned out to be a cancer in the bone.

**Takeaway:** When encountering a non-healing ulcer with localized bone loss and a loose prosthesis, maintain a high index of suspicion for malignancy and think laterally beyond generalized periodontal disease.

## Case: Floor of mouth ulcer and blocked submandibular gland

### Question

**Scenario:** A patient presents with a blocked submandibular gland or an asymptomatic lesion on the floor of the mouth and ventral tongue.

**What's shown:** An intraoral clinical photograph showing the floor of the mouth.

**Consider:** What is the likely cause of the blocked submandibular gland and the appearance of the ulcer?


### Answer

**Observations:**
- Non-healing ulcer
- Indurated lesion

**Reasoning:** Tumors on the ventral tongue or floor of the mouth can be painless and go unnoticed by the patient. They may present as a blocked submandibular gland because the tumor surrounds the duct opening, preventing it from emptying. Unlike a salivary stone, which causes intermittent blockage that resolves, a tumor-induced blockage will not improve and presents with a different clinical appearance.

**Outcome:** The lesion is a tumor causing duct obstruction.

**Takeaway:** When a patient presents with a blocked submandibular gland, think laterally about tumors on the floor of the mouth or ventral tongue, especially if the blockage does not resolve like a salivary stone would.

## Case: Maxillary swelling with localized bone loss

### Question

**Scenario:** A patient presents with a swelling in the minor salivary gland area of the maxilla.

**What's shown:** Intraoral clinical photographs of the maxilla and a panoramic radiograph (OPG).

**Consider:** What is the diagnosis for a swelling accompanied by localized bone loss and a loose tooth?


### Answer

**Observations:**
- Swelling in the minor salivary gland area
- Huge amount of localized bone loss on the OPG
- Very loose tooth

**Reasoning:** The initial thought for a swelling is usually an infection, prompting a check of tooth vitality, cracks, and restorations. However, the OPG reveals sudden, massive localized bone loss and a loose tooth, which points away from a simple dental infection and suggests a malignancy.

**Outcome:** Diagnosed as a lymphoma.

**Takeaway:** While infection is the first consideration for a swelling, localized severe bone loss and tooth mobility on a radiograph should raise suspicion for a malignancy such as lymphoma.
</text>
    <formatted_text>## Case: Lower anterior non-healing ulcer and localized bone loss

### Question

**Scenario:** A patient presents with a non-healing ulcer in the lower anterior region, a loose bridge, and food impaction.

**What's shown:** A panoramic radiograph (OPG) and an intraoral clinical photograph of the lower anterior region.

**Consider:** What should be considered when bone loss and a non-healing ulcer are localized to one specific area rather than being generalized?


![](W3 Oral Cancer - Foo_cases_attachments/img_74363d1e9c3f44bc.webp)
![](W3 Oral Cancer - Foo_cases_attachments/img_06cb50b40e554ce1.webp)
### Answer

**Observations:**
- Generalized bone loss, but with more severe, localized bone loss around the lower anteriors (specifically noted around teeth 4 and 2).
- A non-healing ulcer in the lower anterior region.
- A loose bridge and food impaction in the affected area.

**Reasoning:** While bone loss is most commonly due to periodontal disease, localized bone loss combined with a non-healing ulcer in a specific area should prompt lateral thinking. It is important to consider other causes, such as a malignancy or local infection, rather than assuming it is solely periodontal disease.

**Outcome:** The area was investigated and the findings turned out to be a cancer in the bone.

**Takeaway:** When encountering a non-healing ulcer with localized bone loss and a loose prosthesis, maintain a high index of suspicion for malignancy and think laterally beyond generalized periodontal disease.

## Case: Floor of mouth ulcer and blocked submandibular gland

### Question

**Scenario:** A patient presents with a blocked submandibular gland or an asymptomatic lesion on the floor of the mouth and ventral tongue.

**What's shown:** An intraoral clinical photograph showing the floor of the mouth.

**Consider:** What is the likely cause of the blocked submandibular gland and the appearance of the ulcer?


![](W3 Oral Cancer - Foo_cases_attachments/img_3f13a8dba0752aaf.webp)
![](W3 Oral Cancer - Foo_cases_attachments/img_67c3671039cfa144.webp)
### Answer

**Observations:**
- Non-healing ulcer
- Indurated lesion

**Reasoning:** Tumors on the ventral tongue or floor of the mouth can be painless and go unnoticed by the patient. They may present as a blocked submandibular gland because the tumor surrounds the duct opening, preventing it from emptying. Unlike a salivary stone, which causes intermittent blockage that resolves, a tumor-induced blockage will not improve and presents with a different clinical appearance.

**Outcome:** The lesion is a tumor causing duct obstruction.

**Takeaway:** When a patient presents with a blocked submandibular gland, think laterally about tumors on the floor of the mouth or ventral tongue, especially if the blockage does not resolve like a salivary stone would.

## Case: Maxillary swelling with localized bone loss

### Question

**Scenario:** A patient presents with a swelling in the minor salivary gland area of the maxilla.

**What's shown:** Intraoral clinical photographs of the maxilla and a panoramic radiograph (OPG).

**Consider:** What is the diagnosis for a swelling accompanied by localized bone loss and a loose tooth?


![](W3 Oral Cancer - Foo_cases_attachments/img_61632d6690212fd6.webp)
### Answer

**Observations:**
- Swelling in the minor salivary gland area
- Huge amount of localized bone loss on the OPG
- Very loose tooth

**Reasoning:** The initial thought for a swelling is usually an infection, prompting a check of tooth vitality, cracks, and restorations. However, the OPG reveals sudden, massive localized bone loss and a loose tooth, which points away from a simple dental infection and suggests a malignancy.

**Outcome:** Diagnosed as a lymphoma.

**Takeaway:** While infection is the first consideration for a swelling, localized severe bone loss and tooth mobility on a radiograph should raise suspicion for a malignancy such as lymphoma.
</formatted_text>
    <heading_path>Case: Lower anterior non-healing ulcer and localized bone loss</heading_path>
    <images>
      <img order="0" type="photo" path="W3 Oral Cancer - Foo_figures/img_74363d1e9c3f44bc.webp" media="frame" source="slide" page="5" timestamp="00:04:52">
        <description>Clinical photo showing an intraoral view of the lower anterior teeth and gingiva. A large, ulcerated lesion with a necrotic center and raised borders is visible on the lower gum line between the teeth.</description>
      </img>
      <img order="1" type="figure" path="W3 Oral Cancer - Foo_figures/img_06cb50b40e554ce1.webp" media="frame" source="slide" page="5" timestamp="00:04:52">
        <description>Radiograph: A panoramic dental X-ray (orthopantomogram) showing the maxilla and mandible. The image displays multiple teeth, including several with radiopaque restorations or crowns, as well as evidence of tooth loss in various regions.</description>
      </img>
      <img order="2" type="photo" path="W3 Oral Cancer - Foo_figures/img_3f13a8dba0752aaf.webp" media="frame" source="slide" page="6" timestamp="00:08:55">
        <description>Clinical photograph showing the lateral aspect of a human tongue with a visible pathological lesion. The mass appears as an irregular, erythematous (red) and white area on the side of the tongue, featuring central ulceration and raised borders.</description>
      </img>
      <img order="3" type="photo" path="W3 Oral Cancer - Foo_figures/img_67c3671039cfa144.webp" media="frame" source="slide" page="6" timestamp="00:08:55">
        <description>Clinical photo: An intraoral view showing a raised, irregular red lesion on the lateral aspect of the tongue. The lesion appears exophytic and erythematous with a granular texture, contrasting with the surrounding pink mucosa.</description>
      </img>
      <img order="4" type="photo" path="W3 Oral Cancer - Foo_figures/img_61632d6690212fd6.webp" media="frame" source="slide" page="7" timestamp="00:10:30">
        <description>Clinical photo: An intraoral view showing the floor of the mouth and anterior mandibular teeth. A raised, irregular, erythematous lesion is visible on the soft tissue in the midline near the frenulum.</description>
      </img>
    </images>
  </page>
  <page number="49" origin="cases">
    <text>## Case: Mandibular metastasis on CT scan

### Question

**Scenario:** A patient with a metastatic lesion in the mandible.

**What's shown:** Axial and 3D reconstructed CT scans of the mandible.

**Consider:** Identify the radiographic findings on the CT scans.


### Answer

**Observations:**
- Bone loss
- An area of lump in the mandible

**Reasoning:** The CT scan reveals bone loss and a lump in the mandible, which in this case represents metastasis.

**Outcome:** None stated.

**Takeaway:** Metastasis to the mandible can present radiographically as bone loss and a lump on CT imaging.

## Case: Mucosal melanoma of the oral cavity and uvula

### Question

**Scenario:** A patient presenting with a pigmented oral lesion.

**What's shown:** Clinical photographs of the oral cavity showing a pigmented lesion invading the soft tissue, and an intraoral view showing a tumor invading the uvula.

**Consider:** Identify the clinical features and the functional impact of the lesion.


### Answer

**Observations:**
- Pigmented lesion invading the soft tissue
- Mobile teeth that bleed easily
- Bone loss from bone invasion
- Tumor invading the uvula

**Reasoning:** The extensive pigmented lesion with soft tissue invasion, tooth mobility, and bone loss is characteristic of mucosal melanoma rather than a simple dark spot. Invasion of the uvula and soft palate impairs their function in sealing off the nasal cavity, leading to a nasal voice.

**Outcome:** None stated.

**Takeaway:** Mucosal melanoma presents as an extensive pigmented lesion with soft tissue invasion, tooth mobility, and bone loss, and can impair palatal function causing a nasal voice.

## Case: Pre-radiotherapy dental assessment form

### Question

**Scenario:** A patient with hypopharyngeal squamous cell carcinoma is referred for a pre-radiotherapy dental assessment prior to receiving post-operative radiotherapy.

**What's shown:** A dental evaluation form detailing the proposed radiation dose (66Gy/33) and a chart indicating the specific radiation dose planned for individual upper and lower teeth (ranging from 40Gy to 66Gy).

**Consider:** How to use the radiation field and dose information to decide which teeth should be extracted prior to treatment.

### Answer

**Observations:**
- The chart indicates that some teeth will receive 40Gy of radiation, while others will receive 66Gy.

**Reasoning:** The lecturer explains that the radiation dose determines the risk of complications, such as poor healing, if extractions are needed later. Teeth receiving 55Gy or more are at high risk; if there is any doubt about their long-term prognosis—such as having a 7mm periodontal pocket, a huge MOD restoration, or being heavily restored—they should be extracted pre-radiotherapy. Teeth receiving a much lower dose (e.g., 40Gy) can be given the benefit of the doubt and monitored.

**Outcome:** The patient is assessed to render them dentally fit before radiotherapy, aiming to avoid extractions within the high-dose radiation field after treatment has commenced.

**Takeaway:** The threshold for pre-radiotherapy extraction of questionable teeth is typically a radiation dose of 55 Gy or more to avoid post-treatment complications.

## Case: Mobile posterior tooth and non-healing white patch

### Question

**Scenario:** A patient presents with an unusually mobile tooth 48 and a non-healing white patch in the adjacent posterior mandibular region.

**What's shown:** An intraoral clinical photograph of the posterior mandible and a panoramic radiograph (OPG).

**Consider:** What do the clinical and radiographic findings indicate, and what surgical approach is required?

</text>
    <formatted_text>## Case: Mandibular metastasis on CT scan

### Question

**Scenario:** A patient with a metastatic lesion in the mandible.

**What's shown:** Axial and 3D reconstructed CT scans of the mandible.

**Consider:** Identify the radiographic findings on the CT scans.


![](W3 Oral Cancer - Foo_cases_attachments/img_8b2ba7095e2c001a.webp)
![](W3 Oral Cancer - Foo_cases_attachments/img_fa13e42947145fbd.webp)
### Answer

**Observations:**
- Bone loss
- An area of lump in the mandible

**Reasoning:** The CT scan reveals bone loss and a lump in the mandible, which in this case represents metastasis.

**Outcome:** None stated.

**Takeaway:** Metastasis to the mandible can present radiographically as bone loss and a lump on CT imaging.

## Case: Mucosal melanoma of the oral cavity and uvula

### Question

**Scenario:** A patient presenting with a pigmented oral lesion.

**What's shown:** Clinical photographs of the oral cavity showing a pigmented lesion invading the soft tissue, and an intraoral view showing a tumor invading the uvula.

**Consider:** Identify the clinical features and the functional impact of the lesion.


![](W3 Oral Cancer - Foo_cases_attachments/img_ca3d4cb4e402d477.webp)
![](W3 Oral Cancer - Foo_cases_attachments/img_ccd00fe207148f1e.webp)
### Answer

**Observations:**
- Pigmented lesion invading the soft tissue
- Mobile teeth that bleed easily
- Bone loss from bone invasion
- Tumor invading the uvula

**Reasoning:** The extensive pigmented lesion with soft tissue invasion, tooth mobility, and bone loss is characteristic of mucosal melanoma rather than a simple dark spot. Invasion of the uvula and soft palate impairs their function in sealing off the nasal cavity, leading to a nasal voice.

**Outcome:** None stated.

**Takeaway:** Mucosal melanoma presents as an extensive pigmented lesion with soft tissue invasion, tooth mobility, and bone loss, and can impair palatal function causing a nasal voice.

## Case: Pre-radiotherapy dental assessment form

### Question

**Scenario:** A patient with hypopharyngeal squamous cell carcinoma is referred for a pre-radiotherapy dental assessment prior to receiving post-operative radiotherapy.

**What's shown:** A dental evaluation form detailing the proposed radiation dose (66Gy/33) and a chart indicating the specific radiation dose planned for individual upper and lower teeth (ranging from 40Gy to 66Gy).

**Consider:** How to use the radiation field and dose information to decide which teeth should be extracted prior to treatment.

### Answer

**Observations:**
- The chart indicates that some teeth will receive 40Gy of radiation, while others will receive 66Gy.

**Reasoning:** The lecturer explains that the radiation dose determines the risk of complications, such as poor healing, if extractions are needed later. Teeth receiving 55Gy or more are at high risk; if there is any doubt about their long-term prognosis—such as having a 7mm periodontal pocket, a huge MOD restoration, or being heavily restored—they should be extracted pre-radiotherapy. Teeth receiving a much lower dose (e.g., 40Gy) can be given the benefit of the doubt and monitored.

**Outcome:** The patient is assessed to render them dentally fit before radiotherapy, aiming to avoid extractions within the high-dose radiation field after treatment has commenced.

**Takeaway:** The threshold for pre-radiotherapy extraction of questionable teeth is typically a radiation dose of 55 Gy or more to avoid post-treatment complications.

## Case: Mobile posterior tooth and non-healing white patch

### Question

**Scenario:** A patient presents with an unusually mobile tooth 48 and a non-healing white patch in the adjacent posterior mandibular region.

**What's shown:** An intraoral clinical photograph of the posterior mandible and a panoramic radiograph (OPG).

**Consider:** What do the clinical and radiographic findings indicate, and what surgical approach is required?


![](W3 Oral Cancer - Foo_cases_attachments/img_cbece681b57f489a.webp)
![](W3 Oral Cancer - Foo_cases_attachments/img_e0ec36b93208a1b1.webp)
![](W3 Oral Cancer - Foo_cases_attachments/img_e347c955e2824afd.webp)</formatted_text>
    <heading_path>Case: Mandibular metastasis on CT scan</heading_path>
    <images>
      <img order="0" type="figure" path="W3 Oral Cancer - Foo_figures/img_8b2ba7095e2c001a.webp" media="frame" source="slide" page="10" timestamp="00:15:17">
        <description>A 3D reconstructed computed tomography (CT) scan of a human skull shown in an anterior view. The image reveals a large, destructive radiolucent lesion involving the left mandibular body and ramus, characterized by significant bone loss and a pathological fracture through the affected area.</description>
      </img>
      <img order="1" type="figure" path="W3 Oral Cancer - Foo_figures/img_fa13e42947145fbd.webp" media="frame" source="slide" page="10" timestamp="00:15:17">
        <description>Radiograph: An axial computed tomography (CT) scan of the maxillofacial region showing a cross-section of the jaws. The image displays high-density structures corresponding to teeth and bone, with a notable area of radiolucency (darkness) and structural disruption in the left posterior maxilla/zygomatic region, consistent with osteolytic metastatic disease.</description>
      </img>
      <img order="2" type="photo" path="W3 Oral Cancer - Foo_figures/img_ca3d4cb4e402d477.webp" media="frame" source="slide" page="11" timestamp="00:15:31">
        <description>Clinical photograph showing an intraoral view of the oral cavity, specifically highlighting a large, irregular, reddish mass or lesion located on the soft palate and uvula area.</description>
      </img>
      <img order="3" type="photo" path="W3 Oral Cancer - Foo_figures/img_ccd00fe207148f1e.webp" media="frame" source="slide" page="11" timestamp="00:15:31">
        <description>A Clinical photograph showing the oral cavity with a large, dark purple-black mass involving the upper gingiva and hard palate. The lesion appears raised and nodular, with some areas of surface ulceration or whitish discoloration, extending from the gum line up towards the roof of the mouth.</description>
      </img>
      <img order="4" type="photo" path="W3 Oral Cancer - Foo_figures/img_cbece681b57f489a.webp" media="frame" source="slide" page="42" timestamp="01:01:17">
        <description>Clinical intraoral photograph showing the posterior mandibular region with visible teeth and gingival tissue. The image displays a lesion on the alveolar mucosa, appearing as an irregular area of mixed redness and whitish texture adjacent to the molars.</description>
      </img>
      <img order="5" type="photo" path="W3 Oral Cancer - Foo_figures/img_e0ec36b93208a1b1.webp" media="frame" source="slide" page="42" timestamp="01:01:17">
        <description>Clinical photo: A panoramic dental radiograph displaying the maxilla and mandible, showing multiple teeth with restorations and significant bone loss. The image illustrates a large radiolucent lesion in the right mandibular region (viewer's left), consistent with the slide context of squamous cell carcinoma.</description>
      </img>
      <img order="6" type="photo" path="W3 Oral Cancer - Foo_figures/img_e347c955e2824afd.webp" media="frame" source="slide" page="43" timestamp="01:02:00">
        <description>This is a panoramic radiograph showing the post-operative reconstruction of the right mandible. A large metallic reconstruction plate with multiple screws bridges a segmental defect in the lower jaw, securing the remaining bone segments together.</description>
      </img>
    </images>
  </page>
  <page number="50" origin="cases">
    <text>### Answer

**Observations:**
- Tooth 48 is unusually mobile.
- A non-healing white patch is present in the area behind the tooth.
- The panoramic radiograph (OPG) reveals an area of bone erosion in the mandible.

**Reasoning:** 
- Biopsy of the non-healing white patch confirmed it was a carcinoma (transcribed in the lecture as &quot;fcc&quot;). 
- The radiographic bone erosion indicates that the lesion has invaded the hard tissue of the mandible. 
- Because the tumor has eroded the bone, the surgical resection must include the mandible, not just the soft tissue.

**Outcome:** 
- The patient underwent resection of the tumor and the affected portion of the mandible. 
- The defect was reconstructed using a large reconstruction plate and bone harvested from the leg to replace the missing hard tissue.

**Takeaway:** 
- When an oral carcinoma erodes the underlying mandibular bone, surgical management requires resection of the bone and reconstruction with both hard and soft tissue (e.g., a bone graft from the leg and a reconstruction plate) to restore function.</text>
    <formatted_text>### Answer

**Observations:**
- Tooth 48 is unusually mobile.
- A non-healing white patch is present in the area behind the tooth.
- The panoramic radiograph (OPG) reveals an area of bone erosion in the mandible.

**Reasoning:** 
- Biopsy of the non-healing white patch confirmed it was a carcinoma (transcribed in the lecture as &quot;fcc&quot;). 
- The radiographic bone erosion indicates that the lesion has invaded the hard tissue of the mandible. 
- Because the tumor has eroded the bone, the surgical resection must include the mandible, not just the soft tissue.

**Outcome:** 
- The patient underwent resection of the tumor and the affected portion of the mandible. 
- The defect was reconstructed using a large reconstruction plate and bone harvested from the leg to replace the missing hard tissue.

**Takeaway:** 
- When an oral carcinoma erodes the underlying mandibular bone, surgical management requires resection of the bone and reconstruction with both hard and soft tissue (e.g., a bone graft from the leg and a reconstruction plate) to restore function.</formatted_text>
    <heading_path>Case: Mobile posterior tooth and non-healing white patch &gt; Answer</heading_path>
  </page>
  <footnotes>[^1]: Original PDF page 1: [[W3 Oral Cancer - Foo.pdf#page=1|W3 Oral Cancer - Foo, p.1]]
[^2]: Original PDF page 2: [[W3 Oral Cancer - Foo.pdf#page=2|W3 Oral Cancer - Foo, p.2]]
[^3]: Original PDF page 3: [[W3 Oral Cancer - Foo.pdf#page=3|W3 Oral Cancer - Foo, p.3]]
[^4]: Original PDF page 4: [[W3 Oral Cancer - Foo.pdf#page=4|W3 Oral Cancer - Foo, p.4]]
[^5]: Original PDF page 5: [[W3 Oral Cancer - Foo.pdf#page=5|W3 Oral Cancer - Foo, p.5]]
[^6]: Original PDF page 6: [[W3 Oral Cancer - Foo.pdf#page=6|W3 Oral Cancer - Foo, p.6]]
[^7]: Original PDF page 7: [[W3 Oral Cancer - Foo.pdf#page=7|W3 Oral Cancer - Foo, p.7]]
[^8]: Original PDF page 8: [[W3 Oral Cancer - Foo.pdf#page=8|W3 Oral Cancer - Foo, p.8]]
[^9]: Original PDF page 9: [[W3 Oral Cancer - Foo.pdf#page=9|W3 Oral Cancer - Foo, p.9]]
[^10]: Original PDF page 10: [[W3 Oral Cancer - Foo.pdf#page=10|W3 Oral Cancer - Foo, p.10]]
[^11]: Original PDF page 11: [[W3 Oral Cancer - Foo.pdf#page=11|W3 Oral Cancer - Foo, p.11]]
[^12]: Original PDF page 12: [[W3 Oral Cancer - Foo.pdf#page=12|W3 Oral Cancer - Foo, p.12]]
[^13]: Original PDF page 13: [[W3 Oral Cancer - Foo.pdf#page=13|W3 Oral Cancer - Foo, p.13]]
[^14]: Original PDF page 14: [[W3 Oral Cancer - Foo.pdf#page=14|W3 Oral Cancer - Foo, p.14]]
[^15]: Original PDF page 15: [[W3 Oral Cancer - Foo.pdf#page=15|W3 Oral Cancer - Foo, p.15]]
[^16]: Original PDF page 16: [[W3 Oral Cancer - Foo.pdf#page=16|W3 Oral Cancer - Foo, p.16]]
[^17]: Original PDF page 17: [[W3 Oral Cancer - Foo.pdf#page=17|W3 Oral Cancer - Foo, p.17]]
[^18]: Original PDF page 18: [[W3 Oral Cancer - Foo.pdf#page=18|W3 Oral Cancer - Foo, p.18]]
[^19]: Original PDF page 19: [[W3 Oral Cancer - Foo.pdf#page=19|W3 Oral Cancer - Foo, p.19]]
[^20]: Original PDF page 20: [[W3 Oral Cancer - Foo.pdf#page=20|W3 Oral Cancer - Foo, p.20]]
[^21]: Original PDF page 21: [[W3 Oral Cancer - Foo.pdf#page=21|W3 Oral Cancer - Foo, p.21]]
[^22]: Original PDF page 22: [[W3 Oral Cancer - Foo.pdf#page=22|W3 Oral Cancer - Foo, p.22]]
[^23]: Original PDF page 23: [[W3 Oral Cancer - Foo.pdf#page=23|W3 Oral Cancer - Foo, p.23]]
[^24]: Original PDF page 24: [[W3 Oral Cancer - Foo.pdf#page=24|W3 Oral Cancer - Foo, p.24]]
[^25]: Original PDF page 25: [[W3 Oral Cancer - Foo.pdf#page=25|W3 Oral Cancer - Foo, p.25]]
[^26]: Original PDF page 26: [[W3 Oral Cancer - Foo.pdf#page=26|W3 Oral Cancer - Foo, p.26]]
[^27]: Original PDF page 27: [[W3 Oral Cancer - Foo.pdf#page=27|W3 Oral Cancer - Foo, p.27]]
[^28]: Original PDF page 28: [[W3 Oral Cancer - Foo.pdf#page=28|W3 Oral Cancer - Foo, p.28]]
[^29]: Original PDF page 29: [[W3 Oral Cancer - Foo.pdf#page=29|W3 Oral Cancer - Foo, p.29]]
[^30]: Original PDF page 30: [[W3 Oral Cancer - Foo.pdf#page=30|W3 Oral Cancer - Foo, p.30]]
[^31]: Original PDF page 31: [[W3 Oral Cancer - Foo.pdf#page=31|W3 Oral Cancer - Foo, p.31]]
[^32]: Original PDF page 32: [[W3 Oral Cancer - Foo.pdf#page=32|W3 Oral Cancer - Foo, p.32]]
[^33]: Original PDF page 33: [[W3 Oral Cancer - Foo.pdf#page=33|W3 Oral Cancer - Foo, p.33]]
[^34]: Original PDF page 34: [[W3 Oral Cancer - Foo.pdf#page=34|W3 Oral Cancer - Foo, p.34]]
[^35]: Original PDF page 35: [[W3 Oral Cancer - Foo.pdf#page=35|W3 Oral Cancer - Foo, p.35]]
[^36]: Original PDF page 36: [[W3 Oral Cancer - Foo.pdf#page=36|W3 Oral Cancer - Foo, p.36]]
[^37]: Original PDF page 37: [[W3 Oral Cancer - Foo.pdf#page=37|W3 Oral Cancer - Foo, p.37]]
[^38]: Original PDF page 38: [[W3 Oral Cancer - Foo.pdf#page=38|W3 Oral Cancer - Foo, p.38]]
[^39]: Original PDF page 39: [[W3 Oral Cancer - Foo.pdf#page=39|W3 Oral Cancer - Foo, p.39]]
[^40]: Original PDF page 40: [[W3 Oral Cancer - Foo.pdf#page=40|W3 Oral Cancer - Foo, p.40]]
[^41]: Original PDF page 41: [[W3 Oral Cancer - Foo.pdf#page=41|W3 Oral Cancer - Foo, p.41]]
[^42]: Original PDF page 42: [[W3 Oral Cancer - Foo.pdf#page=42|W3 Oral Cancer - Foo, p.42]]
[^43]: Original PDF page 43: [[W3 Oral Cancer - Foo.pdf#page=43|W3 Oral Cancer - Foo, p.43]]
[^44]: Original PDF page 44: [[W3 Oral Cancer - Foo.pdf#page=44|W3 Oral Cancer - Foo, p.44]]
[^45]: Original PDF page 45: [[W3 Oral Cancer - Foo.pdf#page=45|W3 Oral Cancer - Foo, p.45]]
[^46]: Original PDF page 46: [[W3 Oral Cancer - Foo.pdf#page=46|W3 Oral Cancer - Foo, p.46]]
[^47]: Original PDF page 47: [[W3 Oral Cancer - Foo.pdf#page=47|W3 Oral Cancer - Foo, p.47]]</footnotes>
</document>
